Donate For Public and Patients Store Search

Welcome!

Search


October 3

Learn more about October 3 at aad.org

Are you at risk for pityriasis rubra type V? It’s in the cards!

In a recent post advising to tread lightly before prescribing secukinumab for pityriasis rubra pilaris (PRP), I suggested that the Griffiths classification of PRP be expanded from types I –VI to include type VII (paraneoplastic) and type VIII (Sézary syndrome presenting as PRP). In my opinion, of all the types,

April 3

Learn more about April 3 at aad.org

July 3

Learn more about July 3 at aad.org

Secukinumab for pityriasis rubra pilaris: Tread lightly

Every dermatology resident preparing for their board examination can rattle off Griffiths’ classification of pityriasis rubra pilaris (PRP) – Type I (Classical Adult), Type II (Atypical Adult), Type III (Classic Juvenile), Type IV (Circumscribed Juvenile), and Type V (Atypical Juvenile). Type VI, associated with HIV infection was subsequently added to

Humbled again: Alopecic and aseptic nodules of the scalp

Read the November 3, 2021 DermWorld Insights and Inquiries on alopecic and aseptic nodules of the scalp.

Neurofibromatosis type 1, juvenile xanthogranuloma, and leukemia: Wasting a good worry?

Worry comes with the territory of Neurofibromatosis Type I (NF-1). It often starts with the anxiety of determining if a child has enough criteria to confirm the diagnosis.

Melanoma: Appropriate Surgical Margins — QCDR measure AAD 12

Access reporting information for QCDR measure AAD 12: Melanoma: Appropriate Surgical Margins. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.

3 ways to promote skin cancer awareness this month

Learn more about 3 ways to promote skin cancer awareness this month at aad.org

Melanoma: Appropriate Surgical Margins — QCDR measure AAD 12

Access reporting information for QCDR measure AAD 12: Melanoma: Appropriate Surgical Margins. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.

Lagging ahead: LAG-3 checkpoint inhibition for advanced melanoma

Read the May 11, 2022 DermWorld Insights and Inquiries on LAG-3 checkpoint inhibition for advanced melanoma.

Is dyshidrosiform pemphigoid really anti-p200 pemphigoid?

Dyshidrosiform pemphigoid (DP) was initially reported in a 72 year-old man with large, tense bullae on the plantar aspect of his feet, with some lesions on an erythematous base. He also had an “ill-defined papular eruption” of the trunk and an erosion of the posterior pharynx. Routine microscopy demonstrated a

Getting a leg up on squamous cell carcinomas of the teratoacanthoma type

I thought it was my imagination, but apparently not – there is distinct subset of patients, mostly mature women, with squamous cell carcinomas (SCC) of the keratoacanthoma type (KA) usually presenting on the anterior distal lower extremities.

Time to reassess messing around with steroids and psoriasis

Read the March 3, 2021 DermWorld Insights and Inquiries on reassessing steroids and psoriasis.

American Academy of Dermatology Association Applauds Introduction of The Patients First Act Aimed at Medicare Physician Reform

Statement from Murad Alam, MD, MSCI, MBA, FAAD, President, American Academy of Dermatology Association ROSEMONT, Ill. (July 15, 2026) — The American Academy of Dermatology Association applauds Academy member Representative John Joyce, MD, FAAD (R-PA), for introducing bipartisan, comprehensive Medicare physician payment reform legislation, the Patients First Act. The Academy

Multiple café au lait spots in fair skinned children without evidence of neurofibromatosis type 1: Don’t SPRE(A)D the word – yet

Café au lait spots (CALS) are extraordinarily common; six or more lesions (at least 0.5 cm prior to puberty or 1.5 cm post puberty) are considered one of the criteria for diagnosing neurofibromatosis type I (NF1), and are also seen in a variety of other syndromes.

Clear cell papulosis: Clearly distinctive, clearly underrecognized

Read the June 3, 2020 DermWorld Insights and Inquiries on clear cell papulosis.

Going green: The complexities of the green nail syndrome

Read the February 3, 2021 DermWorld Insights and Inquiries on green nail syndrome.

Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon – Part II – Focus on Anifrolumab

Anifrolumab, a monoclonal antibody that blocks type 1 interferon signaling, has been increasingly reported as an effective treatment in patients with recalcitrant chronic cutaneous lupus erythematosus.

A single case report has the potential to change the world: Could JAK inhibition alter the trajectory of multicentric reticulohistiocytosis?

Read the Aug. 3, 2022 DermWorld Insights and Inquiries on JAK inhibition and multicentric reticulohistiocytosis.

Other emerging severe and resistant dermatophytes of concern

Other emerging dermatophytes of concern include Trichophyton rubrum and Trichophyton mentagrophytes type VII. Learn about treatment and patient counseling.

Melanoma Reporting — Measure 397

Access reporting information on measure 397: Melanoma Reporting. Review the maximum points available, the measure type, measure specifications, and much more.

Melanoma Reporting — Measure 397

Access reporting information on measure 397: Melanoma Reporting. Review the maximum points available, the measure type, measure specifications, and much more.

Advance Care Plan — Measure 47

Access reporting information for MIPS measure 47: Advance Care Plan. Review the maximum points available, the measure type, measure specifications, and more.

Advance Care Plan — Measure 47

Access reporting information for MIPS measure 47: Advance Care Plan. Review the maximum points available, the measure type, measure specifications, and more.

Patient-Centered Surgical Risk Assessment and Communication — Measure 358

Access reporting information on measure 358: Patient-Centered Surgical Risk Assessment and Communication. Review the maximum points available, the measure type, measure specifications, and much more.

Patient-Centered Surgical Risk Assessment and Communication — Measure 358

Access reporting information on measure 358: Patient-Centered Surgical Risk Assessment and Communication. Review the maximum points available, the measure type, measure specifications, and much more.

Veterans Affairs announces new precertification requirement for Regions 1, 2, and 3

The Veterans Affairs Community Care Network (VA CCN) has announced that dermatologists providing care in Regions 1, 2, and 3 should be aware of the new precertification requirements for certain dermatologic procedures, including skin biopsies, soft tissue excision, and adjacent tissue transfer procedures.

Adult Immunization Status — Measure 493

Access reporting information on measure 493: Adult Immunization Status. Review the maximum points available, the measure type, measure specifications, and much more.

Psoriasis: Improvement in Patient-Reported Itch Severity — Measure 485

Access reporting information for MIPS measure 485: Psoriasis: Improvement in Patient-Reported Itch Severity. Review the maximum points available, the measure type, measure specifications, and much more.

Dermatitis: Improvement in Patient-Reported Itch Severity — Measure 486

Access reporting information for MIPS measure 486: Dermatitis: Improvement in Patient-Reported Itch Severity. Review the maximum points available, the measure type, measure specifications, and much more.

Psoriasis: Clinical Response to Systemic Medications — Measure 410

Access reporting information for MIPS measure 410: Psoriasis: Clinical Response to Systemic Medications. Review the maximum points available, the measure type, measure specifications, and much more.

Psoriasis: Improvement in Patient-Reported Itch Severity — Measure 485

Access reporting information for MIPS measure 485: Psoriasis: Improvement in Patient-Reported Itch Severity. Review the maximum points available, the measure type, measure specifications, and much more.

Dermatitis: Improvement in Patient-Reported Itch Severity — Measure 486

Access reporting information for MIPS measure 486: Dermatitis: Improvement in Patient-Reported Itch Severity. Review the maximum points available, the measure type, measure specifications, and much more.

Documentation of Current Medications in the Medical Record — Measure 130

Access reporting information on measure 130: Documentation of Current Medications in the Medical Record. Review the maximum points available, the measure type, measure specifications, and much more.

Documentation of Current Medications in the Medical Record — Measure 130

Access reporting information on measure 130: Documentation of Current Medications in the Medical Record. Review the maximum points available, the measure type, measure specifications, and much more.

Psoriasis: Clinical Response to Systemic Medications — Measure 410

Access reporting information for MIPS measure 410: Psoriasis: Clinical Response to Systemic Medications. Review the maximum points available, the measure type, measure specifications, and much more.

Adult Immunization Status — Measure 493

Access reporting information on measure 493: Adult Immunization Status. Review the maximum points available, the measure type, measure specifications, and much more.

Controlling High Blood Pressure — Measure 236

Access reporting information on measure 236: Controlling High Blood Pressure. Review the maximum points available, the measure type, measure specifications, and much more.

Actinic Keratosis: Self-reported AK Treatment or Management Outcomes — QCDR measure AAD 20

Access reporting information for QCDR measure AAD 20: Actinic Keratosis: Self-reported AK Treatment or Management Outcomes. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.

Closing the Referral Loop: Receipt of Specialist Report — Measure 374

Access reporting information on measure 374: Closing the Referral Loop: Receipt of Specialist Report. Review the maximum points available, the measure type, measure specifications, and much more.

Closing the Referral Loop: Receipt of Specialist Report — Measure 374

Access reporting information on measure 374: Closing the Referral Loop: Receipt of Specialist Report. Review the maximum points available, the measure type, measure specifications, and much more.

Avoidance of Opioid Prescriptions for Closures and Reconstruction After Skin Cancer Resection — QCDR measure AAD 18

Access reporting information for QCDR measure AAD 18: Avoidance of Opioid Prescriptions for Closures and Reconstruction After Skin Cancer Resection. Review the maximum points available, the measure type, measure specifications, and much more.

Chronic Skin Conditions: Patient Reported Quality-of-Life — QCDR measure AAD8

Access reporting information for QCDR measure AAD8: Chronic Skin Conditions: Patient Reported Quality-of-Life. Review the maximum points available, the measure type, measure specifications, and much more.

Screening for Social Drivers of Health — Measure 487

Access reporting information on measure 487: Screening for Social Drivers of Health. Review the maximum points available, the measure type, measure specifications, and much more.

Use of High-Risk Medications in Older Adults — Measure 238

Access reporting information on measure 238: Use of High-Risk Medications in Older Adults. Review the maximum points available, the measure type, measure specifications, and much more.

November 3, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Nov. 3, 2021 ... Facial contact dermatitis from cosmetic allergens DermWorld Insights and Inquiries : Humbled again — Alopecic and aseptic nodules of the scalp Derm Coding Consult : Applying 2021

Gains in Patient Activation Measure (PAM) Scores at 12 Months — Measure 503

Access reporting information on measure 503: Gains in Patient Activation Measure (PAM) Scores at 12 Months. Review the maximum points available, the measure type, measure specifications, and much more.

Incretin-based therapy for diabetes and dermatology: Promise and peril

In a given day, how many of your patients are diabetic? According to the American Diabetes Association, in 2015, 9.4% of the US population (30.3 million) were diabetic; 29 million of this group had type 2 diabetes.

Glomus tumors point a finger at neurofibromatosis

The correct diagnosis of the JAMA Dermatology Clinicopathological Correlation of a glomus tumor presenting as longitudinal erythronychia was straightforward – I was fascinated by this comment in the discussion: “The presence of multiple glomus tumors in the digits should raise suspicion for neurofibromatosis type I” (1).

Gains in Patient Activation Measure (PAM) Scores at 12 Months — Measure 503

Access reporting information on measure 503: Gains in Patient Activation Measure (PAM) Scores at 12 Months. Review the maximum points available, the measure type, measure specifications, and much more.

Teatime for radiation dermatitis (and beyond)

Epigallocatechin-3-gallate, derived from green tea, has many properties with the potential for multiple uses in dermatology when used topically. It may prove especially useful for patients with radiation-induced dermatitis.

The Term “Dermal Hyperneury” Hits a Nerve

I was intrigued by the title “Dermal hyperneury and multiple sclerotic fibromas in multiple endocrine neoplasia type 2A spectrum” by Alegría-Landa et al. (1) [Please see the addendum for the definition of the multiple endocrine neoplasia (MEN) syndromes.]

Decomplexing plexiform neurofibromas

Plexiform neurofibromas (PNs) are some of the most disfiguring and therapeutically challenging lesions that dermatologists confront. PNs are mostly associated with autosomal dominant neurofibromatosis type 1. Rarely, they may also be seen in germline p16 mutation-positive heritable melanoma and Cowden syndrome.

Chronic Skin Conditions: Patient Reported Quality-of-Life — QCDR measure AAD8

Access reporting information for QCDR measure AAD8: Chronic Skin Conditions: Patient Reported Quality-of-Life. Review the maximum points available, the measure type, measure specifications, and much more.

Melanoma: Tracking and Evaluation of Recurrence — Measure 509

Access reporting information on measure 509: Melanoma: Tracking and Evaluation of Recurrence. Review the maximum points available, the measure type, measure specifications, and much more.

Melanoma: Tracking and Evaluation of Recurrence — Measure 509

Access reporting information on measure 509: Melanoma: Tracking and Evaluation of Recurrence. Review the maximum points available, the measure type, measure specifications, and much more.

Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling — Measure 431

Access reporting information on measure 431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling. Review the maximum points available, the measure type, measure specifications, and much more.

Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling — Measure 431

Access reporting information on measure 431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling. Review the maximum points available, the measure type, measure specifications, and much more.

Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented — Measure 317

Access reporting information for MIPS measure 317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented. Review the maximum points available, the measure type, a measure flowchart, measure specifications, and much more.

Biopsy: Reporting Time - Clinician to Patient — QCDR measure AAD 6

Access reporting information on QCDR measure AAD6: Skin Cancer: Biopsy Reporting Time — Clinician to Patient — Measure AAD 6. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.

Biopsy: Reporting Time - Clinician to Patient — QCDR measure AAD 6

Access reporting information on QCDR measure AAD6: Skin Cancer: Biopsy Reporting Time — Clinician to Patient — Measure AAD 6. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.

Plantar melanoma and mechanical stress

Acral lentiginous melanoma (ALM) involves the palms, soles, and nail beds. It is the most common type of melanoma in patients of African or Asian descent. Delays in diagnosis result in more advanced disease at the time of diagnosis.

Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis — QCDR measure AAD15

Access reporting information for QCDR measure AAD 15:Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.

Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis — QCDR measure AAD15

Access reporting information for QCDR measure AAD 15:Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.

Treatments for renal IgA vasculitis are beginning to flow

Renal disease is the most severe complication of IgA vasculitis. New treatments such as iptacopan (an alternative complement inhibitor) and atrasentan (an endothelin type A receptor inhibitor) are promising novel therapies for this challenging disease.

Continuation of Anticoagulation Therapy in the Office-based Setting for Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD 17

Access reporting information for QCDR measure AAD 17: Continuation of Anticoagulation Therapy in the Office-based Setting for Closures and Reconstruction After Skin Cancer Resection Procedures. Review the maximum points available, the measure type, measure specifications, and much more.

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention — Measure 226

Access reporting information on measure 226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention. Review the maximum points available, the measure type, a measure flowchart, measure specifications, and much more.

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention — Measure 226

Access reporting information on measure 226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention. Review the maximum points available, the measure type, a measure flowchart, measure specifications, and much more.

Dermatologist job satisfaction

Facts at your Fingertips ... By Emily Margosian, assistant editor, August 1, 2019 Despite rising burnout rates among all physicians, according to the AAD 2019 Life in Practice Study, the vast majority of dermatologists still enjoy what they do. Overall, 72% — or 7 in 10 dermatologists — say they

Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD16

Access reporting information for QCDR measure AAD16: Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures. Review the maximum points available, the measure type, measure specifications, and much more.

Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD16

Access reporting information for QCDR measure AAD16: Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures. Review the maximum points available, the measure type, measure specifications, and much more.

Dermatology antibiotic prescription trends

Facts at your fingertips ... By Emily Margosian, assistant editor, November 1, 2019 As antibiotic resistance has increasingly captured the attention of the media and global health organizations, physicians have found themselves under more pressure to monitor their antibiotic prescription habits. Although overall antibiotic prescribing by dermatologists decreased by 36.6%

Connection to Community Service Provider — Measure 498

Access reporting information on measure 498: Connection to Community Service Provider. Review the maximum points available, the measure type, measure specifications, and much more.

Quality Resources Provided by the AAD

See a summary of quality resources provided by the Academy, grouped by type.

Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time — Pathologist to Clinician — Measure 440

Access reporting information for MIPS measure 440: Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time — Pathologist to Clinician. Review the maximum points available, the measure type, measure specifications, and much more.

Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time — Pathologist to Clinician — Measure 440

Access reporting information for MIPS measure 440: Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time — Pathologist to Clinician. Review the maximum points available, the measure type, measure specifications, and much more.

Medical research funding

Ask the Expert ... By Victoria Houghton, managing editor, August 1, 2021 DermWorld ... spoke to Jennifer Mangone, JD, manager of congressional policy for the American Academy of Dermatology Association (AADA), about the Academy’s advocacy efforts to support medical research funding. DermWorld: Advocating for medical research funding is a top

Bad online review?

Go to AAD Home ... Go to AAD Home ... Menu ... Dermatology World explains why bad online reviews may not be so bad after all ... Dermatology World explains why bad online reviews may not be so bad after all ... By Ruth Carol, contributing writer Patients are increasingly

Appropriate Documentation and Shared Decision Making of AK — QCDR measure AAD 21

Access reporting information for QCDR measure AAD 21: Appropriate Documentation and Shared Decision Making of AK. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.

Addressing systems and administrative challenges

Running a successful dermatology practice hinges not only on exceptional patient care but also on efficient administration. While challenges vary based on practice type and other factors, most practices face common administrative burdens. These burdens are a major driver of burnout.

Melanoma risk in patients with melaoncortin-1 receptor independent of ultraviolet radiation: Is there a way not to be burned by your genome?

I admit that my concept of Type I skin red-headed patients getting melanoma was simple: They have a polymorphism(s) of the melanocortin-1 receptor (MC1R), pheomelanin, ultraviolet exposure, DNA damage, increased reactive oxygen species, and voila: melanoma! While conceptually elegant, this is apparently only a partial truth.

May 3, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 3, 2023 ... Oral oxybutyloride for hidradenitis suppurativa patients? DermWorld Insights and Inquiries : Necrobiosis lipoidica in a Wink Exposure to anesthesia and alopecia areata Do study authors accurately report

April 3, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 3, 2024 ... Safety of DEET insect repellent in children: Do the natural alternatives work? DermWorld Insights and Inquiries : Hair straightening and acute renal injury — The latest data

Actinic Keratosis: Self-reported AK Treatment or Management Outcomes - National Quality Strategy Domain: Patient Experience — QCDR measure AAD 20

Access reporting information for QCDR measure AAD 20: Actinic Keratosis: Self-reported AK Treatment or Management Outcomes - National Quality Strategy Domain: Patient Experience. This measure was developed by the AAD. Review the maximum points available, the measure type, measure specifications, and much more.

Necrobiosis lipoidica in a Wink

Read the May 3, 2023 DermWorld Insights and Inquiries on Necrobiosis lipoidica in a Wink. Necrobiosis lipoidica is usually associated with diabetes, but may also be accompanied by thyroid disease, hypertension, hyperlipidemia, and other disorders. JAK inhibitors are on the horizon in treating the granulomatous component of the disorder.

The retiring type?

“Tell me, Dr. Heymann, when do you plan to retire?” Patients seem to ask me that every day. My usual response: “Why do you ask, do I look that bad?” “No, you look pretty good for your age.” (According to my rabbi, there are three stages of life – youth, middle age, and

Types of audits

There are four different types of Medicare contractors that are responsible for auditing records, claims, and payments. While each type of contractor can use different methods to conduct the appeals, they all must be compliant with Medicare guidelines for medical review, denials, appeals, and payment recovery.

Ustekinumab: A topic for atopics?

If you’re like me, you have a cadre of patients with severe atopic dermatitis (AD) patients who are counting the minutes for the release of dupilimab (a human monoclonal antibody against interleukin-4 receptor alpha, that inhibits signaling of interleukin-4 and interleukin-13, type 2 cytokines that may be important drivers of

Do skin cancer rates differ by transplanted organ type and patient age?

Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, March 1, 2023 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Lee Wheless, MD,

Propranolol for infantile hemangiomas: Start to finish

Propranolol is first-line therapy for patients with infantile hemangiomas that warrant therapeutic intervention. Studies suggest that starting at the targeted dose and maintaining therapy until age 13 months and 3 months after the lesion has regressed may be appropriate management guidelines.

January 3, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 3, 2024 ... Efficacy of minoxidil for cancer treatment–induced hair loss DermWorld Insights and Inquiries : Malignant syphilis — History in the making Most effective medications for plaque psoriasis Cardiovascular,

March 3, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 3, 2021 ... The latest on the association between diet and acne DermWorld Insights and Inquiries : Time to reassess messing around with steroids and psoriasis Is intralesional 5-FU effective

October 12, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 12, 2022 ... Type 2 diabetes and CCCA severity DermWorld Insights and Inquiries : Fixing the concept of the neutrophilic fixed drug eruption What’s the risk of IBD in patients

August 3, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 3, 2022 ... Dutasteride microinjections with oral minoxidil vs. oral minoxidil for androgenetic alopecia DermWorld Insights and Inquiries : Infantile digital fibromatosis – Inclusions and exclusions CMS outlines payment changes

February 3, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 3, 2021 ... How effective are oral hair growth supplements? DermWorld Insights and Inquiries : Going green — The complexities of the green nail syndrome A practical guide for managing

September 3, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 3, 2025 ... Comparison of botulinum toxin A formulations for treating glabellar strain DermWorld Insights and Inquiries : Trichobacteriosis — A salute to the Shelleys Academy mourns the passing of

December 3, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Dec. 3, 2025 ... GLP-1s and telogen effluvium DermWorld Insights and Inquiries : Pityriasis rosea and pityriasis rosea-like eruptions — A Christmas tale Combination oral minoxidil and baricitinib for alopecia areata

July 3, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 3, 2024 ... Tazarotene vs. imiquimod in patients with plane warts DermWorld Insights and Inquiries : Fire ant stings: From pain to gain — The therapeutic potential of solenopsin Efficacy

June 3, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 3, 2026 ... Risk of cardiovascular events with 5-alpha-reductase inhibitors in androgenetic alopecia DermWorld Insights and Inquiries : A potential roadMAP for treating malignant atrophic papulosis Yellow nail syndrome: Diagnosis

June 3, 2020

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 3, 2020 ... COVID-19 and androgenetic alopecia: Is there a link? DW Insights and Inquiries : Clear cell papulosis — Clearly distinctive, clearly underrecognized Register for the Academy’s virtual meeting

AADA advocates for innovative teledermatology policies and programs

While 85 million Americans are impacted by skin disease, only 1 in 3 patients will see a dermatologist. The Academy believes that teledermatology is a powerful tool for increasing patient access to needed dermatologic care. The Academy advocates for innovative teledermatology policies and programs that increase access to care for

Tofacitinib for dermatomyositis: A potential belle of the ball?

JAK1/3 signaling participates in the pathogenesis of inflammatory disorders while JAK1/2 signaling plays a role in the development of several malignancies including leukemias, lymphomas, and myeloproliferative neoplasms. Tofacitinib (Xeljans) is a pan-JAK inhibitor that is approved by the FDA for the treatment of rheumatoid arthritis and ruxolitinib (Jakafi) is a

Biopsy coding in 2019: Part 3

Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, January 1, 2019 Test your knowledge: Biopsy coding in 2019 — Part 3 ... Take the quiz to see

Step 1: Check participation requirements

The first step of the Academy's 3-step MIPS guide enables dermatologists to determine whether they are exempt from MIPS reporting. Dermatologists who do not meet certain Medicare participation thresholds are not subject to MIPS reimbursement penalties, though they optionally participate to earn incentives.

Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented — Measure 317

Access reporting information for MIPS measure 317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented. Review the maximum points available, the measure type, a measure flowchart, measure specifications, and much more.

Evaluation and management in 2021: Part 3

Cracking the code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, November 1, 2020 Test your knowledge: Evaluation and management in 2021: Part 3 ... Take the quiz to see

October 23, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 23, 2024 ... Botulinum toxin type A with topical minoxidil vs. topical minoxidil alone in males with androgenetic alopecia DermWorld Insights and Inquiries : Shocking news — Heat shock protein

This month’s news from across the specialty

What’s hot ... March 1, 2026 In this monthly column, members of the  DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty.   Harry Dao Jr., MD, FAAD Injectable biologics remain the gold standard for achieving optimal clinical responses in psoriasis, but fear of injections leads many

New treatments provide more options for people with alopecia areata

Journal of the American Academy of Dermatology ... article highlights new ways to restore hair ROSEMONT, Ill. (Aug. 15, 2023) — A study published today in a supplement of the ... Journal of the American Academy of Dermatology titled " ... Alopecia: A New Frontier " reveals that a new

New study reveals that some children with common form of eczema should also be tested for allergic reactions

Study author highlights test used to differentiate between two types of eczema ROSEMONT, Ill. (September 26, 2023) — Eczema, which is a group of medical conditions that causes inflamed, irritated, and often itchy skin, affects millions of people worldwide. A new article published in the ... Journal of the American

As molecular knowledge of PROS expands, lesions contract

Somatic activating mutations in the phosphatidylinositol-3-kinase/AKT/mTOR pathway manifest as heterogeneous segmental overgrowth phenotypes Historically, the clinical diagnoses in patients with PIK3CA activating mutations have included Fibroadipose Hyperplasia or Overgrowth (FAO), Hemihyperplasia Multiple Lipomatosis (HHML), Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, Scoliosis/Skeletal and Spinal (CLOVES) syndrome, macrodactyly, Fibroadipose Infiltrating Lipomatosis,

Becoming pro-geriatric by understanding progeria

I have never seen a case of Hutchinson-Gilford progeria syndrome (HGPS). You probably haven’t either, given its incidence of 1 in 4 million. Why comment on a disease that will likely only be seen in a texbook?

Diagnosing pyoderma gangrenosum? Consider cocaine/levamisole as a potential culprit!

The authors presented 8 patients with PG following exposure to levamisole-contaminated cocaine. All patients had lower extremity involvement, and 6 also had PG on the upper extremities. Retiform purpura was only observed in 3 patients. Most had elevated titers for p-ANCA and antiphospholipid antibodies. Histologic examination was predominantly neutrophilic, consistent

Cimetidine offers a ray of sunshine for patients With erythropoietic protoporphyria

Only once in a great while an article makes me want to break into my happy dance – the report of 3 pediatric cases of erythropoietic protoporhyria (EPP) by Tu et al had that effect. Recently, I ran a post on EPP where I discussed the new findings of EPP

July 31, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 31, 2024 ... Does an increase in omega-3 fatty acids improve acne? DermWorld Insights and Inquiries : Which treatment modality of pyogenic granuloma is worth its weight in salt? Is

What are the effects of nemolizumab treatment in prurigo nodularis patients?

Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, July 1, 2024 In this month’s Clinical Applications column, DermWorld ... Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Shawn

Tressed to impress: tips for keeping your mane magnificent

6 tips for healthier looking and feeling hair from a board-certified dermatologist ROSEMONT, Ill. (Aug. 13, 2024) — Hair is as unique as its wearer, making care an important aspect in one’s overall health and wellness routine. From understanding your hair type to learning the best shampooing technique (yes, there

AAD letter to the New York Times in response to “3 Medical Routines that Older People May Not Need”

American Academy of Dermatology President Murad Alam, MD, MSCI, MBA, FAAD Letter to the editor originally submitted to the New York Times ... on May 4, 2026 ROSEMONT, Ill. (May 4, 2026) — 3 Medical Routines that Older People May Not Need , by Paula Span, imprudently suggests that patients

August 8, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 9, 2023 ... Emerging treatments for itch in atopic dermatitis DermWorld Insights and Inquiries : Prior authorization audits and innovations — Are we finally reducing the (PA)in? Adverse events in

Is there a genetic basis of CCCA and, if so what is it?

Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, July 1, 2019 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Amy McMichael, MD, about her

Malpractice insurance 101

Experts offer advice on navigating malpractice insurance policies. ... Feature ... By Andrea Niermeier, Contributing Writer, February 1, 2025 While medical malpractice suits first regularly appeared in the United States in the 1800s, the frequency of claims has only increased since the 1960s, with lawsuits relatively common today. Medical malpractice

MUE, MAI, and you

Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, June 3, 2019 Test your knowledge: MUE, MAI, and you ... Take the quiz to see if you're up

This month’s news from across the specialty

What’s hot ... August 1, 2024 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Maureen Offiah, MD, FAAD Several physician groups have recently modified the ... staging and classification of all primary cutaneous lymphomas (PCL). Changes to

Unrestricted fascination with restrictive dermopathy

Read the Nov. 16, 2022 DermWorld Insights and Inquiries on restrictive dermopathy.

What are the updated guidelines of care for the management of primary cutaneous melanoma?

Acta Eruditorum ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, December 3, 2018 In this month’s Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Susan M. Swetter, MD, and

DermWorld Weekly comparing efficacy of JAK inhibitors used in alopecia areata

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 22, 2023 ... Comparing efficacy of JAK inhibitors used in alopecia areata DermWorld Insights and Inquiries : Resorcinol’s resourcefulness in hidradenitis suppurativa Derm Coding Consult : CMS Targeted Probe and

April 27, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 27, 2022 ... A novel treatment for molluscum contagiosum? DermWorld Insights and Inquiries : Eye-opening news about oxymetazoline Trends in prescribing spironolactone for acne, HS in adolescents Racial biases in

Session handouts and meetings archive

View previous AAD meeting sessions, handouts, poster exhibits, and floor plans.

Eosinophilic pustular folliculitis: Six decades of progress

DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, March 1, 2026 Vol. 8, No. 3 Eosinophilic pustular folliculitis (EPF) is a quizzical disorder. In 1965, Ise and Ofuji described the case of a 42-year-old woman who "repeatedly developed crops of small pustules on the face, the trunk,

Are teens tanning less?

Go to AAD Home ... Go to AAD Home ... Menu ... Signs point to progress, but work remains ... Signs point to progress, but work remains ... By Ruth Carol, contributing writer It appears that fewer teens are indoor tanning in recent years, but the data are sparse. Regulations

Using trusts to shield assets from potential liability

Money Matters ... David B. Snyder, JD, CLU ... ® ... , is an attorney, author, and financial advisor at the wealth management firm OJM Group. He covers financial issues for dermatologists in this quarterly ... Dermatology World column. ... By David B. Snyder, JD, CLU, September 3, 2018 Given

For better or worse technology is changing medicine.

From the President ... Dr. Olbricht served as Academy president from March 2018 to March 2019. ... By Suzanne Olbricht, MD, September 3, 2018 When is the last time you looked at a paper map or met with a travel agent to book your next adventure? Advances in technology have

August 19, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 19, 2026 ... Potassium hydroxide vs. diclofenac for actinic keratosis DermWorld What’s Hot: Increase in tanning for Gen Z Tirzepatide-associated morbilliform drug eruption Energy-based devices for acne in skin of

Intermediate and complex repairs 2020: Part 1

Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, October 1, 2019 Test your knowledge: Intermediate and complex repairs 2020 — Part 1 ... Take the quiz to

Membership Committee portal

Welcome to the American Academy of Dermatology’s Membership Committee portal. The portal houses applications and their supporting documentation along with resources to help determine eligibility for membership. ... Applicant Name ... Type ... Category ... Country ... Status ... Review {{application.fullName}} ... {{application.pendingMemberType}} ... {{application.pendingMemberCategory}} ... {{application.businessAddressCountry}} ... {{application.status}} ...

Preventing payment appeals

Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, October 3, 2016 Prior Cracking the Code columns have focused upon common billing errors and appeals strategies. However, a

Looking beyond ‘Ozempic face’

Dermatologists weigh in on cutaneous side effects of GLP-1 agonists. ... Feature ... By Emily Margosian, Senior Editor, November 1, 2025 Glucagon-like-peptide-1 (GLP-1) agonists are an emerging class of medications used to manage type 2 diabetes mellitus (T2DM) and weight loss, with demonstrated efficacy in reducing hemoglobin A1c levels, body

Maximizing your retirement wealth

Money Matters ... David B. Snyder, JD, CLU ... ® ... , is an attorney, author, and financial advisor at the wealth management firm OJM Group. He covers financial issues for dermatologists in this quarterly ... Dermatology World column. ... By David B. Synder, JD, CLU, December 3, 2018 For

March

Issue ... March January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... I always knew firefighting was a dangerous occupation What’s hot ... This month’s news from across the specialty Clinical Applications ... Do skin cancer

This month’s news from across the specialty

What’s hot ... May 1, 2026 In this monthly column, members of the  DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty.   Jason Lee, MD, FAAD The incidence of melanoma in situ has increased to epidemic proportions, rising 50-fold since 1975. Lentigo maligna is the most

The doctor will see you...soon?

Facts at your Fingertips ... By Emily Margosian, assistant editor, July 1, 2019 As efforts to improve access to dermatologic care remain ongoing (Read ... Dermatology World ’s 2017 feature "Access Granted" at ... www.aad.org/dw/monthly/2017/october/access-granted for strategies to broaden patient access), how long can the average patient expect to wait

November 18, 2020

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / November 18, 2020 ... Hydrogen peroxide and the common wart: Phase 2 results are in DermWorld Insights and Inquiries : Granulomatous slack skin — More than one type of mimicry FDA

Using gene expression profiling to identify risk of melanoma metastasis

Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, June 3, 2019 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Sancy Leachman, MD, PhD, about

Melanoma incidence rising, deaths decreasing

Facts at your fingertips ... By Emily Margosian, assistant editor, December 1, 2019 According to data from the National Institutes of Health (NIH) Surveillance, Epidemiology, and End Results Program (SEER), there were an estimated 96,480 new cases of melanoma of the skin in 2019 — making it the fifth most

Demand for cosmetic procedures resumes after COVID

Facts at your Fingertips ... By Emily Margosian, Assistant Editor, April 1, 2023 During the start of the COVID-19 pandemic, many practices paused elective and cosmetic procedures for several weeks, followed by further disruptions due to the ebb and flow in national and regional caseloads. ... The release of new

Ransomware attacks on U.S. health care double

Facts at your Fingertips ... By Emily Margosian, Assistant Editor, February 1, 2024 Ransomware is on the rise. A recent ... JAMA Health Forum study found that the annual number of ransomware attacks on health care organizations more than doubled from 2016 to 2021, exposing the personal health information (PHI)

COVID’s impact on cosmetic procedures

Facts at your fingertips ... By Emily Margosian, Assistant Editor, April 1, 2022 During the start of the COVID-19 pandemic, many practices paused elective and cosmetic procedures for several weeks, followed by further disruptions throughout the year due to the ebb and flow in national and regional caseloads. The release

Telemedicine: Reimbursement liability patient consent and HIPAA

Legally Speaking ... Robert M. Portman, JD, MPP, is a health care attorney with Powers Pyles Sutter & Verville, in Washington, D.C. ... By Robert M. Portman, JD, MPP, Rebecca Burke, JD, and Christina L. Krysinski, JD, September 3, 2018 This month, we follow up on our May 2018 column

Glucose monitors: Not as sweet as they seem

Learn more about Glucose monitors: Not as sweet as they seem at aad.org

Recognizing Trichophyton indotineae

In the last decade, a recently emerged dermatophyte species, Trichophyton indotineae, has been causing major outbreaks of severe, difficult-to-treat, and frequently relapsing infections in South Asia among immunocompetent patients.

AAD membership at a glance

Facts at your Fingertips ... By Emily Margosian, content specialist, June 1, 2018 Which way are the winds of dermatology blowing? AAD membership data may serve as a bellwether. In 2018, overall membership surpassed 20,000 dermatologists, but beyond hitting the 20K mark, other demographic changes regarding gender and practice type

Literature request form

Please note that fields marked with an asterisk are required to submit the form.The boxes handle more text than their size dictates. Standard service is 3-7 days. You cannot submit the form without a budget code. If you require assistance with this form, contact Charniel McDaniels at x1823. ... If

December 24, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Dec. 24, 2025 ... Warts: Local hyperthermia with hydrogen peroxide DermWorld Insights and Inquiries : Holiday greeting 2025 Academy mourns the passing of Alfred W. Kopf, MD FDA alert flags cosmetic

Protect your ability to practice

Money Matters ... David B. Snyder, JD, CLU ... ® ... , is an attorney, author, and financial advisor at the wealth management firm OJM Group. He covers financial issues for dermatologists in this quarterly ... Dermatology World column. ... By David B. Snyder, JD, CLU, June 3, 2019 For

Advocacy Update Feb 3, 2026

The Academy continues to monitor the current partial government shutdown and its impact on dermatologists. The funding bill that is in debate includes HHS with Department of Homeland Security funding.

What's hot?

What's hot ... February 26, 2019 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD ... Isn’t it interesting how some common warts that we treat seem to go away almost instantly but others persist

Double check, pause...and proceed

What dermatologists can learn from quality efforts in surgery ... Feature ... By Emily Margosian, content specialist, October 3, 2016 As the culture of health care and developing regulatory trends continue to move in an increasingly quality-focused direction, dermatologists may soon find themselves under more scrutiny. Wrong-site surgery is one

4 cradle cap tips from dermatologists

Tips from board-certified dermatologists ROSEMONT, Ill. (August 18, 2022) — Bringing home a new baby is a joyous time for any parent. For first time parents, bringing home a new baby can unlock a wide range of emotions—from excitement to nervousness. As you adjust to parenthood, you’ll notice that your

CBD: Potential or placebo?

Go to AAD Home ... Go to AAD Home ... Menu ... Potential applications and concerns regarding the use of cannabinoids in dermatology ... Potential applications and concerns regarding the use of cannabinoids in dermatology ... By Emily Margosian, assistant editor This recent Mother’s Day holiday, shoppers may have observed

How to prevent keloid scars

Board-certified dermatologist shares tips to reduce your risk ROSEMONT, Ill. (Dec. 6, 2023) — Keloids are a type of raised scar that can occur after an injury, and over time they can grow much larger than the wound itself. Although keloids are not dangerous to a person’s health, they can

September 9, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 9, 2026 ... Does estrogen therapy affect menopausal hair loss? DermWorld What’s Hot: Discordance in diagnosis of melanocytic neoplasms Derm Coding Consult : VA announces new precertification requirement for Regions

Biopsy coding in 2019: Part 2

Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, December 3, 2018 Test your knowledge: Biopsy coding in 2019 — Part 2 ... Take the quiz to see

How do I claim CME credits from the Annual Meeting?

Asked and Answered ... May 1, 2019 Your CME credits are just a few clicks away! ... To claim AAD meeting credits: ... Visit www.aad.org/evals , or select the CME/Evals icon on the AAD meeting app. If you do not have your registration code, email aadcme@aad.org . To begin claiming

CME & session evaluation archive

Claim CME credit and submit session evaluations for attending previous Academy meetings.

May 11, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 11, 2022 ... Sexual dysfunction associated with finasteride use in men with androgenetic alopecia DermWorld Insights and Inquiries : Lagging ahead — LAG-3 checkpoint inhibition for advanced melanoma FDA grants

September 23, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 23, 2026 ... Local hyperthermia with hydrogen peroxide for warts DermWorld What’s Hot: Molecular profiling of CTCL AAD releases new AD diagnostic testing guidelines Pediatric use of JAK inhibitors and

Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon

Read the Aug. 17, 2022 DermWorld Insights and Inquiries on cutaneous lupus erythematosus and interferon.

June 7, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 7, 2023 ... Treatments for pseudofolliculitis barbae DermWorld Insights and Inquiries : Taking it on the shin – part two Efficacy of abrocitinib for the treatment of lichen sclerosus? Scientists

Biotin supplementation for hair and nail health: Does it pass the test?

Read the November 17, 2021 DermWorld Insights and Inquiries on biotin supplementation for hair and nail health.

Alleviate the ouch

Experts share best practices and review the latest on safety concerns for anesthesia use in children. ... Feature ... By Heidi Splete, Contributing Writer, May 1, 2024 Use of anesthesia can be tricky in adults, but even trickier in children. The use of local or general anesthesia in pediatric dermatology

Up in the air

Go to AAD Home ... Go to AAD Home ... Menu ... With the country embroiled in a public health crisis, how much will the 2020 elections inform health care policy? ... With the country embroiled in a public health crisis, how much will the 2020 elections inform health care

Monthly Archives

Issue ... September January February March April May June July August September View digital flipbook In this issue ... From the Editor ... Keeping up is hard to do What’s hot ... This month’s news from across the specialty DermWorld Insights and Inquiries ... The likely Lilliputian meaning of eosinophils

August

Issue ... August January February March April May June July August September View digital flipbook In this issue ... From the Editor ... Keeping up is hard to do What’s hot ... This month’s news from across the specialty DermWorld Insights and Inquiries ... The likely Lilliputian meaning of eosinophils

Most contact dermatitis patients don’t receive patch testing

Data suggests patch testing is largely underused. ... Facts at your Fingertips ... By Megan Bennett, Staff Writer, August 1, 2026 Only one in 10 adults diagnosed with allergic contact dermatitis (ACD) — and even fewer pediatric patients — have undergone patch testing, according to DataDerm™ figures recently published in

I'm confused about the new biopsy codes. Does the Academy offer any resources to help?

Asked and Answered ... June 3, 2019 Absolutely. ... The Academy recently published an update to the online ... Practice Management Center featuring: ... Quick guides Downloadable reference tools Interactive quizzes Need help now? ... Use these tip sheets for practical guidance on common coding: ... www.aad.org/practicecenter/coding-and-reimbursement/coding-resource-center/coding-tip-sheets . ... Still

Dermatology practice staff by the numbers

Facts at your Fingertips ... By Emily Margosian, July 2, 2018 Nurses, aestheticians, billers — who’s most likely to be spotted working in the average dermatology practice? Aside from dermatologists, medical assistants and practice administrators are the most widely employed across all practice settings, according the 2017 AAD Practice Profile

Contract reimbursement review

When deciding whether to sign a contract with a payer, reimbursement is one of the most important considerations. Adequate reimbursement is critical to the viability of your practice. Therefore, be sure to review contract language on reimbursement carefully. ... Aspects of reimbursement are often negotiable, though the extent to which

October 30, 2024

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 30, 2024 ... Breast health outcomes in women on oral 5-alpha reductase inhibitors D ermWorld Insights and Inquiries : The breathless complications of anti-MDA-5-positive dermatomyositis What symptoms are most significantly

May 18, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 18, 2022 ... Abrocitinib efficacy after switching from dupilumab DermWorld Insights and Inquiries : Coming to grips with lymphocytic thrombophilic arteritis DermWorld Young Physician Focus : Protecting dermatologic scope of

How can I get a receipt for payments made to the Academy?

Asked and Answered ... March 1, 2020 For all Academy-related payments — membership dues, past orders, a subscription to ... Dialogues in Dermatology — AAD members can access their receipts as follows: ... 1. Visit ... www.aad.org/members 2. Sign in to your member profile ... 3. Click the "Account" tab

How can I use DataDerm to report for MIPS?

Asked and Answered ... November 29, 2018 DataDerm™ can help you report for all three MIPS categories in 2018: ... Quality Promoting interoperability (PI) Improvement activities (IA) Here’s how to get started: ... 1. Step one: Sign up. ... Complete the sign-up portal at ... https://dataderm.aad.org/signup/Login.aspx by ... Dec. 7,

Evaluation and management: Selecting the codes

Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, September 3, 2018 You have evaluated a patient, and now it is time to select an appropriate level of

The case for comprehensive patch testing

Acta Eruditorum ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, September 3, 2018 In this month’s Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Jenny E. Murase, MD, about

Twenty years of imiquimod taking its toll on lentigo maligna — Where are we?

Read the February 12, 2020 DermWorld Insight and Inquiries on treating lentigo maligna.

The woolly culprit: Lanolin revealed as an uncommon cause of dermatitis on normal skin

Lanolin is the 2023 Allergen of the Year and is present in many personal care and industrial products. For those who have a positive patch test to lanolin, it is important to remember the “lanolin paradox” where patients have a positive patch test but tolerate lanolin on normal skin.

AADA hosts largest Capitol Hill skin cancer check in a decade

On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health Fair with the Congressional Skin Cancer Caucus. This event was our largest to date, hosting 198 Hill staffers and 11 members of Congress, performing 127 skin checks, and providing 75 Reveal camera image results.

July 16, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 16, 2025 ... Female pattern hair loss: Is systemic minoxidil effective over the long term? DermWorld Insights and Inquiries : Pathway to clarity — The new and improved Melanocytic Pathology

Academy physician leaders meet with federal legislators

On June 4, AADA physician leaders met with legislators in Washington, D.C., as part of the House Call on the Mall fundraiser hosted by the National Republican Congressional Committee and Rep. John Joyce, MD, FAAD (R-PA). During the event, AADA leaders reiterated the importance of Medicare physician payment reform.

Granulomatous slack skin: More than one type of mimicry

Read the November 18, 2020 DermWorld Insights and Inquiries on granulomatous slack skin.

April 28, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 28, 2021 ... Acne: Clindamycin-tretinoin vs. benzoyl peroxide-adapalene DermWorld Insights and Inquiries: Do not get burned by missing Staphylococcal scalded skin syndrome Is daylight photodynamic therapy effective for actinic keratosis?

December

Issue ... December January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... 2021 What's hot ... This month's news from across the specialty Feature ... COVID-19 and dermatology What have we learned about the cutaneous manifestations

January

Issue ... January January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... From the editor Asked and Answered ... I am on the OLC. Where can I find the JAAD and Dialogues in Dermatology quizzes? What's

November

Issue ... November January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... It’s always the gluten What's hot ... This month's news from across the specialty Clinical Applications ... How is structural racism affecting atopic dermatitis

Despite concerns, dermatologists retain primary control of their practices

Facts at your Fingertips ... By Emily Margosian, assistant editor, June 3, 2019 Amid ongoing debate about the evolution of dermatology practice settings and the role of equity-backing in the specialty, new AAD survey data indicates that dermatologists have maintained both primary ownership and management of their practices. According to

Moving or closing practices? Here's what you need to know.

In Practice ... Faiza Wasif, MPH, is the AAD's practice management manager. Her column offers tips on an area she commonly receives questions about from members. ... By Faiza Wasif, MPH, December 3, 2018 There is a lot you must consider before you move or close your practice including the

How can I get involved with this year’s Legislative Conference?

Asked and Answered ... July 1, 2024 The 2024 AADA Legislative Conference will take place Sept. 8-10, at the JW Marriot in Washington, D.C. ... Attending the conference is as easy as 1, 2, 3. You can expect: ... Two days of networking and learning from political experts about the

Dermatology heads to Capitol Hill

Facts at your Fingertips ... By Emily Margosian, assistant editor, December 3, 2018 The contentious midterm election season has concluded, but the impact from the 2018 AADA Legislative Conference is still going strong. In July, physicians, patients, patient advocates, dermatology nurses, and dermatology practice administrators gathered in Washington, D.C. to

How can I get involved with this year’s Legislative Conference?

Asked and Answered ... July 1, 2023 The 2023 AADA Legislative Conference will take place Sept. 10-12, at the Conrad Hotel, in Washington, D.C. ... Attending the conference is as easy as 1, 2, 3. You can expect: ... Two days of networking and learning from political experts about the

What's hot?

What's hot ... July 24, 2018 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Edward W. Cowen, MD, MHSc ... The first human retrovirus, identified in 1980, was not HIV, but human T-cell lymphotrophic virus-1 (HTLV-1). It

This month's news from across the specialty

What's hot ... February 1, 2020 In this monthly column, members of  ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty.   ... EDWARD COHEN, MD, MHSc Apremilast, an oral inhibitor of phosphodiesterase 4, was approved in 2014 for the treatment of psoriasis and psoriatic

FAQs - Coding for Intermediate and Complex Repairs in 2020 and beyond

Q: Are there any changes to the Simple Repair guidelines? A: No, the simple repair guidelines will remain unchanged for 2020 and beyond. ... Q: How should I code a nasal tip excision, for which the defect is repaired with a linear layered closure (3 cutaneous and 5 super-ficial sutures)

Injecting ideas (and therapies) in digital mucous cysts

Digital mucous (myxoid) cysts are often associated with osteoarthritis. Multiple therapeutic maneuvers may be utilized, but the best results remain with surgical excision.

New evaluation and management (E/M) coding changes are coming in 2021 – Practical applications of the 2021 E/M coding changes

Selecting the E/M level of service ... Part 3 of the "E/M coding changes are coming in 2021" series will focus on the practical application of the changes to dermatology-specific encounters based on ... medical decision making (MDM) or ... time . (Review ... part 1 and ... part 2

Should benign cephalic histiocytosis be renamed? Let’s keep our heads about this decision.

Benign cephalic histiocytosis (BCH) is a rare non-Langerhans cell histiocytic disorder first recognized by Gianotti 46 years ago. (1) Over the years, I have seen several cases of both Langerhans cell histiocytosis (LCH), and non-Langerhans cell histiocytoses, but do not recall ever having seen BCH.

Doing our part to make a difference

From the President ... Dr. Hruza served as Academy president from March 2019 to March 2020. ... By George Hruza, MD, MBA, June 3, 2019 "When you think about yourself, skip the only,’ as in I’m only a surgeon’ or I’m only a dermatologist.’ Think about what needs to be

Reflecting on 2018 with gratitude

From the President ... Dr. Olbricht served as Academy president from March 2018 to March 2019. ... By Suzanne Olbricht, MD, December 3, 2018 Legendary crooner Andy Williams may have said it best in his song, "It’s the Most Wonderful Time of the Year." Holidays aside, for me this time

From the editor

From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, September 3, 2018 I have learned many new things from the past few editors of ... Dermatology World . This edition is no exception. I know much more about microneedling than I

From the editor

From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, December 3, 2018 Christmas came early for dermatology. Indeed, it came early for all of medicine this year when the Centers for Medicare and Medicaid Services (CMS) released its final rule implementing

Body dysmorphic syndrome

Legally Speaking ... Clifford Warren Lober, MD, JD, presents legal dilemmas in dermatology every other month. He is a dermatologist in practice in Florida and a partner in the law firm Lober, Brown, and Lober. ... By Clifford Warren Lober, MD, JD, December 3, 2018 Lori: Bryan, I recently excised

This month’s news from across the specialty

What’s hot ... November 1, 2023 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Craig Burkhart, MD, MS, MPH, FAAD All medical fields can learn from their past mistakes. The path to modern medical practice was not

From the editor

From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, June 3, 2019 You asked, we listened. We had an outstanding response to our readership survey this year (thanks to all of you who took the time to offer your thoughts and

Obituaries

Obituaries ... By Jerry Graff, MD, June 3, 2019 The Academy recently learned with sorrow of the passing of the following members of the dermatologic community. ... JON GARRY BEIDLER, MD, of Chambersburg, Pennsylvania, Dec. 30, 2018, at age 82. Trained in dermatology at University of Pennsylvania and practiced in

Reducing the burden of clinical documentation with EHRs

In Practice ... By Swapna Bhatia, MPH, June 3, 2019 It’s no surprise that clinical and administration documentation burden with electronic health records (EHRs) has been on the rise. ... Although 78% of dermatology practices reported acquiring an EHR system in the 2017 AAD Practice Profile Survey, the Academy recognizes

This month’s news from across the specialty

What’s hot ... July 1, 2025 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Michael A. Marchetti, MD, FAAD Although management options for chronic spontaneous urticaria (CSU) improved with the introduction of the anti-IgE monoclonal antibody omalizumab

Viva ex vivo dermoscopy?

It has been said that the best “special stain” is a deeper section – wise words indeed. While always gratifying to discover pathology not present on original sections, it is also humbling to ponder the number of incorrect diagnoses because deeper sections are not obtained.

Triskaidekaphobia legitimized: Fatal Factor XIII deficiency

Read the April 12, 2023 DermWorld Insights and Inquiries on triskaidekaphobia legitimized and fatal factor XIII deficiency.

Researching therapeutic reformation of the capillary malformation: Arteriovenous Malformation Syndrome

Read the June 17, 2020 DermWorld Insights and Inquiries on capillary malformation.

AADA hosts 10th annual Capitol Hill Skin Cancer Check and Health Fair

Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, May 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health

Wait no more

In Practice ... By Victoria Houghton, managing editor, September 3, 2018 Dermatology World talks with Benjamin Chong, MD, MSCS service chief of dermatology at Parkland Health and Hospital System in Dallas about how he addressed long wait times. ... Dermatology World: Describe the access issues with the dermatology clinic at

Workplace violence

Legally Speaking ... Clifford Warren Lober, MD, JD, presents legal dilemmas in dermatology every other month. He is a dermatologist in practice in Florida and a partner in the law firm Lober, Brown, and Lober. ... By Clifford Warren Lober, MD, JD, June 3, 2019 Question: What is workplace violence?

Fixating on doxycycline-induced fixed drug eruptions

Dermatologists routinely prescribe doxycycline. Historically, doxycycline rarely causes a fixed drug eruption. A case series of patients with doxycycline-induced fixed drug eruptions in patients receiving doxycycline for post-exposure prophylaxis or treatment of sexually transmitted disease has been reported. More study is required to determine if the incidence of doxycycline-induced fixed

Taking the challenge: Social media, adolescents, and the skin

Learn more about Taking the challenge: Social media, adolescents, and the skin at aad.org

October 30, 2019

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 30, 2019 ... Potential treatment for chronic urticaria may offer complete control DW Insights and Inquiries: Can chowing down improve pseudoxanthoma elasticum? Advances in medical technology: friend or foe? Do

Keeping up

Dermatologists discuss the various methods for staying current with the latest medical research ... Feature ... By Ruth Carol, contributing writer, August 1, 2021 With an estimated 33,000 peer-reviewed, English-language, scientific journals and more than 3 million articles published each year, it’s no wonder that staying current with the medical

2026 AADA Legislative Conference: Program and agenda

Learn more about the policy-focused sessions during the 2026 AADA Legislative Conference.

Dupilumab: The first year

When introduced as dermatologist to a new acquaintance, I’m sure you have heard: “Dermatology is a great field – you don’t cure anybody, so they keep coming back!” Trust me. It’s no joy to see patients with recalcitrant, severe, life-altering, debilitating diseases such as atopic dermatitis, psoriasis, recalcitrant mycosis fungoides, et

A medal-worthy diagnosis: Medallion-like dermal dendrocyte hamartoma

he clinically distinctive medallion-like dermal dendrocyte hamartoma is a benign lesion that must be differentiated from congenital atrophic dermatofibrosarcoma protuberans, especially in patients with adenosine deaminase-deficient severe combined immunodeficiency.

Advocacy Update May 5, 2026

In response to advocacy by the AADA and other specialty societies, UnitedHealth Care will delay any adverse payment decisions related to Medicare Advantage referral requirements starting on May 1.

What is the path forward for treating children with severe atopic dermatitis with dupilumab?

Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, March 1, 2021 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Amy Paller, MD, about her

2025 AADA Legislative Conference: Program and agenda

Learn more about the policy-focused sessions during the 2025 AADA Legislative Conference.

Documentation and reporting requirements for adjacent tissue transfer or rearrangement

Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Senior Manager, Coding and Reimbursement, June 1, 2025 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . Adjacent tissue transfer (ATT) or rearrangement procedures

Deep penetrating thoughts about deep penetrating nevi

What do the terms “intermediate” and “indeterminate” mean to you?

A shot in the dark

Read the March 10, 2021 DermWorld Insights and Inquiries on COVID arm.

Vascular Ehlers-Danlos syndrome: From rupture to rapture?

Read the February 16, 2022 DermWorld Insights and Inquiries on Vascular Ehlers-Danlos syndrome.

Rejecting preconceived notions of squamous cell carcinomas in patients experiencing transplant rejections

Learn more about Rejecting preconceived notions of squamous cell carcinomas in patients experiencing transplant rejections at aad.org

August 21

Learn more about August 21 at aad.org

Payer advocacy: Prior authorization

The Academy advocates that prior authorization determinations should be standardized, and the speed of determination should be quantified and minimized. Unduly delays and poorly designed prior authorization protocols can cause irreparable harm to patients.

Applying the 2021 E/M coding concepts in everyday practice – Part 3

The introduction of the revised 2021 evaluation and management (E/M) coding guidelines has generated a plethora of questions from dermatologists in the application of the concepts used in the medical-decision making table (MDM). To help members navigate the E/M changes in a simplified and relatable manner in everyday practice, the

Digital media kit: E-newsletter rates and specs

Reach the full AAD membership weekly, approximately more than 16,000 globally, with two e-newsletters, DermWorld Weekly and DermWorld Academy Insider.

Vascular abnormalities in FFA, artificial intelligence, and Winston Churchill

Dilated, depressed frontal veins are a clinical sign of frontal fibrosing alopecia.

Advocacy Update Jun 3, 2025

The AADA continues discussions with CMS advocating for revisions to recent CLIA requirements to ensure that all board-certified dermatologists are approved as lab directors of dermatology labs.

February 16, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 16, 2022 ... A review of calcipotriol plus 5-fluorouracil for actinic keratosis DermWorld Insights and Inquiries : Vascular Ehlers-Danlos syndrome: From rupture to rapture? Delayed complications for FDA-approved HA dermal

Advocacy Update March 3, 2026

The AADA has actively engaged CMS around training requirements for dermatologists performing SRT.

What's hot?

What's hot ... March 27, 2018 In this monthly column, members of ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty. ... Edward W. Cowen, MD, MHSc ... Alopecia areata is frustrating to patients, parents, and practitioners, all of whom may be left with unsatisfactory

Hairdressers’ dermatologic odyssey: From dye to death prevention

My younger daughter Deborah was destined to be a hair stylist. When she was a camper in the Poconos, I received an urgent call from the staff about her. Assuming the worst, my heart palpitating in fear, all I could do was laugh when I was informed that she violated

Stepping back from the abyss: A kinder, gentler variant of calciphylaxis

My reaction to the diagnosis of calciphylaxis is Pavlovian – I automatically think about an end-stage renal insufficiency patient with an abysmal prognosis. Increasingly there are reports of nonuremic forms of the disease, where the prognosis may not be as bleak (*although clinically very significant).

Key messages to communicate about Indoor tanning

By communicating these key messages on indoor tanning, you can help position the specialty while increasing your credibility and raising the profile of your practice.

Vaccines, maintenance, and PEP

Learn about vaccine status based on birth year and high-risk individuals who should have vaccine boosters. Also, see our resources on post-exposure prophylaxis (PEP) and administering immunoglobulin.

The rhythm of RIME

Read the March 2, 2022 DermWorld Insights and Inquiries on RIME.

The profound dermatological manifestations of COVID-19 Part VI: Going to the dogs

Read the July 29, 2020 DermWorld Insights and Inquiries on the COVID-19 pandemic.

Advocacy Update Jul 22, 2025

The AADA submitted nomination materials recommending AADA Dermatopathology Committee Chair Alina Bridges, DO, FAAD, for membership on the CDC’s Advisory Committee to the Director.

Sézary syndrome and Shakespeare: What’s in a name?

O Sézary, Sézary! Wherefore art thou Sézary? Deny thy erythema and refuse thy name Or, if thou wilt not, but sworn by biome, And you’ll no longer be a syndrome. Dermatologists have contended with entities such as zoster sine herpete and aleukemic leukemia cutis, but now reports of Sézary syndrome (SS) without erythroderma challenge

Maximizing knowledge about infantile hemangioma with minimal or arrested growth

Knowledge about hemangiomas is proliferating at a rate the compares with the first few days of an infantile hemangioma (IH) itself. Over the past decade a “new” lesion is coming into focus – the infantile hemangioma with minimal or arrested growth (IH-MAG).

Professionalism and Ethics

The AAD’s Professionalism and Ethics Committee has proposed a five-part voluntary statement, now ratified by the AAD Board of Directors. The statement sets the basic framework for an ethical practice; it is not designed to set unattainable or unrealistic standards. As such, it is hoped that AAD members will strive

September 22, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 22, 2021 ... What treatment is most effective for refractory spontaneous urticaria? DermWorld Insights and Inquiries : Following up on "A Trend I Cannot Endorse" DermWorld Young Physician Focus :

Advocacy Update Feb. 4 2025

The AADA is pleased that physician champions in the U.S. House introduced a bipartisan bill to address the 2025 Medicare Physician Fee Schedule cut.

Advocacy Update June 30, 2026

AADA President Murad Alam, MD, MSCI, MBA, FAAD, met with federal legislators on Medicare physician payment reform in Washington, DC.

Bringing pigmented lupus to light

Lettie (not her real name) was an elderly, charming, courtly, soft-spoken African-American woman whose facial skin was getting progressively darker. Only after I drew routine laboratory studies and found marked thrombocytopenia, did I entertain the diagnosis of lupus, which was subsequently confirmed by biopsy and serologies.

Dermatology coding essentials part 3: Pearls, pitfalls, and best practices

Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Senior Manager, Coding & Reimbursement, August 1, 2026 Academy coding staff address important coding topics each month in DermWorld Coding Consult. ... Read more Derm Coding Consult articles . As we continue sharing pearls, pitfalls, and

Sweating over sweat gland carcinomas: Part 2 — Eccrine mucin-producing sweat gland carcinoma

Eccrine mucin-producing sweat gland carcinomas are low-grade malignancies that rarely metastasize. They are characterized by mucin and neuroendocrine markers. Immunostaining for insulinoma-associated protein 1 helps to secure the diagnosis.

The opioid epidemic: Coma blisters and beyond

The opioid crisis in the United States is responsible for at least 90 fatalities every day. This dire situation has been aggravated by the increased availability of very potent synthetic opioids such as fentanyl and carfentanil, which are 50 and 5000 times as potent as heroin, respectively. According to Volkow

Taking psoriasis by the throat

Once the transient satisfaction of explaining the association of streptococcal infections with psoriasis (guttate, vulgaris, or pustulosis palmaris et plantaris) passes, the reality of treatment must be addressed. Of course we’ll prescribe the usual regimens – topical steroids, phototherapy, retinoids, biologics, etc., but targeting the streptococcal trigger should be considered.

March 25, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 25, 2026 ... Finasteride and dutasteride: Depression, suicidal ideation DermWorld What’s Hot: Need for expanded patch testing FDA approves icotrokinra for plaque psoriasis Cutaneous malignancy after biologic therapy Adverse events

How dry I am: The white scale sign of xerosis

When winter approaches my skin dries out. Fortunately, it doesn’t bother me at all. For others, especially in the elderly, xerosis be a predisposing factor for asteototic eczema, nummular dermatitis or dyshidrotic eczema.

Clinical and therapeutic judgment regarding confluent and reticulated papillomatosis of Gougerot and Carteaud

Confluent and Reticulated Papillomatosis of Gougerot and Carteaud is usually seen in adolescents and young adults. Antibiotics (most commonly minocycline or doxycycline) are first-line therapy. The etiology of CARP remains to be determined, and further studies will judge its precise relationship to acanthosis nigricans.

Advocacy Update Dec 9, 2025

The AADA endorsed a House bill that would include an annual inflationary update to the Medicare physician fee schedule, the Academy’s top federal advocacy priority.

Surviving and thriving after a natural disaster

Answers in Practice ... By Emily Margosian, Assistant Editor, September 1, 2023 DermWorld ... talks to Mary Lupo, MD, FAAD, from the Lupo Center for Aesthetic and General Dermatology in New Orleans, about how to prepare your practice for a natural disaster. Mary Lupo, MD, FAAD ... DermWorld: Tell us

State advocacy win: Step therapy reform enacted in Alaska

A step therapy and prior authorization reform bill enacted in Alaska will require insurers to establish a streamlined prior authorization process that minimizes administrative burdens on physicians. The legislation provided a clear and convenient process for requesting exceptions to step therapy protocols and conditions for automatic approval of step therapy

A bridge from the view: Switching from glass to digital dermatopathology

Eight months ago, I started using the Clearpath digital dermatopathology system developed by Tom Olsen and his associates at the Dermatopathology Laboratory Central States (DLCS). As one of the early utilizers, I was grateful to work with his software wizards, offering my perspectives on how to optimize the digital experience.

No Surprises Act

Read Academy analysis of the No Surprises Act (NSA) and its impact on dermatology. The NSA provides patients with new protections against surprise billing because of insurance network rules. Like other clinicians, dermatologists must follow new NSA rules beginning on Jan. 1, 2022. The rules were issued jointly by HHS

Truth in advertising

... Alabama Licensure identification Board certification (BC) Derm-specific BC Misleading advertising Licensees are prohibited from using a title in which in any way represents such person as engaged in the practice of any branch of the healing arts for which such person holds no license. ... n/a ... n/a

January 6, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 6, 2021 ... Managing pain in hidradenitis suppurativa patients: A proposed algorithm DermWorld Insights and Inquiries : Itching to see if polymerase chain reaction mite be the future of diagnosing

September 15, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 15, 2021 ... Worsening psoriasis after COVID-19 vaccination DermWorld Insights and Inquiries : Is ivermectin an old drug with new tricks? Frontal fibrosing alopecia and facial care products Biden administration

After 23 years, a syndrome converted me into an eflornithine believer

Polyamines are integrally involved with the hair cycle. The Bachmann-Bupp syndrome has shed new light on the role of ornithine decarboxylase, and how it’s inhibition by eflornithine can be used as an advantage to either slow or stimulate hair growth.

Crystallizing thoughts about crystalglobulinemia

Every resident asks me if and when they will become confident about their level of knowledge. My answer is simple and consistent – never. This perception was reinforced by perusing the outstanding review of cutaneous paraprotein deposits by Alegría-Landa et al, that included a discussion of “crystalglobulinemia” (1); I was

Methotrexate toxicity: What’s in a name?

I was called to the ICU to assess the dramatic presentation of a woman with hemorrhagic labial crusting and erosive psoriatic plaques. Despite my long-standing familiarity with methotrexate (MTX) I had never encountered a patient with flagrant MTX toxicity.

Hair straightening and acute renal injury: The latest data straight up

An increasing number of reports implicate acute kidney injury due to hair straighteners containing glyoxylic acid.

Elmer Fudd beware: Tularemia’s re-emergence

Practicing dermatology is humbling business. I tip my hat to Polat et al, who diagnosed tularemia in an 11 year-old girl presenting with targetoid papules and plaques of her face, trunk, and extremities (diagnosed as erythema multiforme minor).

Predicting malignancies in Sweet syndrome has become sweeter

For a disease that was described more than half a century ago, I find it humbling that controversy still swirls around Sweet syndrome (SS), especially for malignancy-associated cases.

Is there a best approach to widespread actinic keratoses?

Learn more about Is there a best approach to widespread actinic keratoses? at aad.org

Advocacy Update Feb. 18 2025

The AADA joined over 130 national and state physician organizations led by the AMA demanding Congress act to reform Medicare physician payment.

Advocacy Update July 21, 2026

New legislation introduced would modernize the Medicare physician payment system.

Advocacy Update July 28, 2026

President’s message on Academy’s efforts on fighting proposed Dermatology cuts.

Advocacy Update Mar. 18, 2025

The AADA is outraged that Congress once again passed a government funding bill that did not include relief to stop this year’s 2.8% Medicare physician payment cut.

Darier disease is rough clinically and therapeutically. MEK inhibition may offer a smoother future

MEK inhibition may be a new therapeutic pathway to treat disorders demonstrating focal acantholytic dyskeratosis, including Darier disease and Grover disease.

CMS prior authorization final regulation incorporates AADA’s recommendations

The AADA advocated for these specific prior authorization reforms, which will take effect in 2026. While the regulations currently apply only to Medicare, Medicare Advantage, Medicaid, and CHIP plans and not to private, commercial, and ERISA plans, the AADA anticipates that many private health plans will adopt similar policies.

Educating the public – Choose a derm

How many people can we reach through this campaign? Here’s some context. Fifteen members of the AAD’s Social Media Ambassador team who have committed to participating in the Choose A Dermatologist campaign have the potential to reach about 470,000 followers. Imagine how many followers we can reach if you and

The alphabetization of lymphomatoid papulosis: Focus on “F”

The 50th anniversary of Warren Macaulay’s seminal description of lymphomatoid papulosis (LyP) is approaching.

Optimizing financial efficiency: Part 3

Experts offer advice on best practices for monitoring and auditing income. ... Feature ... By Megan Bennett, Staff Writer , July 1, 2026 The dermatologist sees their patient, finalizes their notes, closes the chart, and submits their claims. ... However, the revenue cycle is far from over. ... Careful consideration

Standard postoperative wound care practice may be all wet

Water exposure in the immediate postoperative period does not increase the risk of infection and allows the patient to continue their water-related hygiene routines.

Slivers of skin may diagnose silver hair syndromes

Simple tests may help distinguish the rare silver hair syndromes (SHS): Chediak-Higashi (CHS) and Griscelli (GS).

The nexus of VEXAS syndrome

Read the December 1, 2021 DermWorld Insights and Inquiries on VEXAS syndrome.

August 12, 2026

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 12, 2026 ... Intralesional acyclovir vs. cryotherapy for plantar warts DermWorld What’s Hot: 5-FU/calcipotriol for AKs, keratinocyte carcinomas Is routine antihistamine use recommended for atopic dermatitis? Efficacy of conventional, biologic

CMS prior authorization final regulation incorporates AADA’s recommendations

Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, July 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. The AADA advocated tirelessly for prior authorization reform. As a result, several policy changes will take

April 17

Learn more about April 17 at aad.org

Differentiating lichen planopilaris from chronic cutaneous lupus may be as easy as 1,2,3 (actually CD123)

My last dermatopathology case of the week was that of a woman with scarring alopecia, which was clearly well advanced. Hardly any follicles remained, and on one section there was a small follicular unit with a peri-infundibular mononuclear infiltrate and slight vacuolar alteration of the follicular epithelium. I signed the

May 12, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 12, 2021 ... Telogen effluvium diagnosis during the COVID-19 pandemic DermWorld Insights and Inquiries : For patients with erythropoietic protoporphyria the tide has come in Derm Coding Consult : How

August 13, 2025

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 13, 2025 ... Effects of GLP-1RA on inflammatory skin diseases DermWorld Insights and Inquiries : Sweating over sweat gland carcinomas: Part 1 — Squamoid eccrine ductal carcinoma Beta-HPV virus can

Waiting for Wong

The Wong variant of dermatomyositis was originally described by O’Leary during the Eisenhower administration (1953) and named for Wong during Nixon’s tenure (1969). I have been involved with dermatology since Carter’s term in office (1979). Since that time (Reagan, Bush, Clinton, Bush, Obama) I have yet to see a case

Treating metastatic melanoma: Understanding a brave new world

Acta Eruditorum ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, April 2, 2018 In this month's Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Jane Grant-Kels, MD, and Daniel

The many uses of microneedling

Go to AAD Home ... Go to AAD Home ... Menu ... How it works, potential applications, and what patients should know ... How it works, potential applications, and what patients should know ... By Emily Margosian, assistant editor Once an experimental treatment pioneered through the use of tattoo pistols

Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease

FcRn antagonists, currently approved for treating myasthenia gravis, show potential for treating pemphigus and other autoimmune diseases.  

The expanding horizon of anti-IL-36 therapy

The IL-36/IL-36R axis is crucial in the pathogenesis and treatment of generalized pustular psoriasis. Researchers have demonstrated that this pathway may be instrumental in several other inflammatory dermatoses, as already shown in pyoderma gangrenosum.

May 25, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 25, 2022 ... Placebo regrowth rate in alopecia areata trials DermWorld Insights and Inquiries : The globalization of monkeypox AADA renews calls for iPLEDGE improvements with IPMG, FDA Seeking comments

Diagnosing the primary cutaneous SMARCA4-deficient cutaneous tumor: You don’t know what you got ‘til it’s gone

Dermatologists may rarely encounter SMARCA4-deficient undifferentiated malignant neoplasms, either as primary cutaneous tumors or as metastatic lesions.

Lipschütz ulcers: Not only for women

Read the March 24, 2021 DermWorld Insights and Inquiries on Lipschütz ulcers.

Coming to terms with Louis Brocq and his diagram: Pityriasis lichenoides 2018

As a first-year dermatology resident in 1980, I struggled with the concept of parapsoriasis. In trying to conceptualize the process, I recall being distressed after seeing Louis Brocq’s diagram from his classic paper, “Les parapsoriasis,” published in 1902 — Would I ever understand this? What is the relationship to

A string of (clinical) pearls about drug-induced linear IgA disease

The late sage Wallace Clark taught me that once a diagnosis is secured, thinking ceases. Admittedly in cases of drug-induced linear IgA dermatosis (DI-LAD) that I have encountered (due to vancomycin), once the diagnosis was suspected and confirmed, I never gave it too much thought. Recent findings in the DI-LAD

Impact Report — Vol 3, Issue 1

In this edition of the American Academy of Dermatology/Association Impact Report, we will show you how we advocate on the issues that matter most to you and your patients. We will show how we establish you as the experts so that your patients can feel confident about their care. Finally,

Impact Report — Vol 4, Issue 3

At the Academy, our number one priority is to support our members. To do that, we are consistently evaluating our initiatives and programs to ensure you are getting the most from your membership. See how we support you through advocacy, read about our success in positioning your expertise with the

Impact Report — Vol 5, Issue 3

Your Academy continues to protect and advance our specialty where it matters most. We advocated for fair payment, defended against inappropriate step therapy protocols, raised the visibility of dermatology, expanded CME access, and strengthened our member community.

Impact Report — Vol 3, Issue 2

The AAD/A Impact Report isn’t just a chronicle of Academy wins for our members (although it is that, too), it’s an ongoing confirmation that we are listening to you, responding to your needs, and giving you the tools you require to grow in your profession.

Impact Report — Vol 3, Issue 2

The AAD/A Impact Report isn’t just a chronicle of Academy wins for our members (although it is that, too), it’s an ongoing confirmation that we are listening to you, responding to your needs, and giving you the tools you require to grow in your profession.

Taking woolly hair to heart

Read the October 27, 2021 DermWorld Insights and Inquiries on woolly hair.

Documentation and coding for repairs in dermatology

Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Senior Manager, Coding & Reimbursement, July 1, 2026 Academy coding staff address important coding topics each month in DermWorld Coding Consult. ... Read more Derm Coding Consult articles . Coding for wound repair is influenced by

Getting to the heart of neonatal lupus erythematosus

Read the July 21, 2021 DermWorld Insights and Inquiries on getting to the heart of neonatal lupus erythematosus.

Turning a blind eye on second opinions

When providing second opinions as a dermatologist or dermatopathologist, you may see a clearer picture if you are blinded first.

Dermatologists cannot be lax about acquired cutis laxa

From the time I was a medical student, I have always been fascinated by the “little old man” appearance of patient with cutis laxa (CL).

This month’s news from across the specialty

What’s hot ... June 1, 2026 In this monthly column, members of the  DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty.   Emily Chu, MD, PhD, FAAD Genetic alterations underpinning melanoma have been increasingly well characterized over the last two decades — most notably point mutations

I never wanted chaperones — until now

Learn more about I never wanted chaperones — until now at aad.org

Raising a toast to advances in treating alcohol-induced flushing

Read the November 11, 2020 DermWorld Insights and Inquiries on advances in treating alcohol-induced flushing

The appeal of molecular medicine for the peeling skin syndrome

This may not be the most appropriate dermatologic admission, but as a child, I really enjoyed peeling away my post-sunburn desquamation. What joy ensued when it came off with glistening new skin underneath! Of course, I’m from the “now we know better” generation – this should never happen in 2018

A sweeter approach to treating scleroderma?

We’re like licorice. Not everybody likes licorice, but the people who like licorice really like licorice – Jerry Garcia. Patients with scleroderma may learn to love licorice.

What are keratoacanthomatous lesions of the legs in mature women?

I have an increasing number of patients asking me questions about proliferating keratoacanthoma-like lesions on their shins. “Why am I getting these? Are they cancer? Why do more of them appear after surgery?”

Cannabinoids may elevate therapy for connective tissue diseases to a higher level

Medical “reefer madness” is taking hold in the United States with approximately 10% of cannabis users utilizing it for diverse medical conditions, including dermatologic disorders such as pruritus and atopic dermatitis. To date, at least 28 states allow for the use of medical cannabis. (1)

This month’s news from across the specialty

What’s hot ... August 1, 2023 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Craig Burkhart, MD, MS, MPH, FAAD SARMs is a growing and dangerous social media trend. ... The U.S. Food and Drug Administration (FDA)

This month’s news from across the specialty

What’s hot ... October 1, 2024 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Mallory Abate, MD, FAAD How highly hereditable is melanoma? Prior studies have estimated that genetic predisposition is rare, with as few as 2.5%

Keeping abreast of drug-induced cutaneous lupus

Read the August 4, 2021 DermWorld Insights and Inquiries on drug-induced cutaneous lupus.

The illusions of IgG4-related skin disease

The diagnosis of IgG4-related skin disease requires careful clinical-pathological correlation because of its varied cutaneous presentations. B-cell depletion therapy with biologic agents such as inebilizumab or obexelimab is promising a future surpassing steroid therapy for this disease.

Epidemic of melanoma or epidemic of scrutiny?

Read the May 19, 2021 DermWorld Insights and Inquiries on whether the rise in melanoma diagnoses represents an epidemic of the disease or of clinical scrutiny.

Research suggests connection between hair loss in women and other diseases

Board-certified dermatologist discusses common types of hair loss seen in women with darker skin tones NEW ORLEANS (March 17, 2023) — Hair loss in women can be emotionally devastating and may negatively impact quality of life, and new research suggests that it can also be associated with having other common

Necrotizing infundibular crystalline folliculitis: Not yet crystal clear

Necrotizing infundibular (ostial) crystalline folliculitis is an underrecognized disorder characterized by folliculocentric waxy papules in the seborrheic areas of adult patients. An increasing number of cases are drug related. The diagnosis requires histopathologic confirmation demonstrating intrafollicular filamentous birefringent crystalline deposits.

Shedding light on the hydroa vacciniforme-like lymphoproliferative disorder

Read the September 1, 2021 DermWorld Insights and Inquiries on hydroa vacciniforme-like lymphoproliferative disorder.

The pregnant pause in cutaneous lymphoma

Cutaneous T-cell lymphoma during pregnancy presents unique challenges in preventing disease progression and maintaining fetal viability. Many standard therapies used in the non-gravid state are contraindicated; topical steroids, phototherapy, and interferon are considered safe options. A multidisciplinary approach is necessary for optimal management.

July 15, 2020

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 15, 2020 ... JAAD study demonstrates link between chilblains and COVID-19 DW Insights and Inquiries: Incysting on understanding pilar cysts Derm Coding Consult : Practical applications of 2021 E/M coding

Improvement activities (15%)

Access Academy resources on the Improvement Activities reporting category, which makes up 15% of a dermatologist's MIPS score. Learn about the reporting requirements and the distinction between medium- and high-weighted activities. Clinicians are rewarded for care focused on care coordination, beneficiary engagement, and patient safety.

Of every possible solution for elastosis perforans serpiginosa, fractional carbon dioxide laser may be the best

My initial attraction to dermatology, which still offers great appeal, is the challenge and joy of differential diagnosis and clinical-pathologic correlation. I learned quickly, however, that patients don’t want to be interesting – they want a specific diagnosis for one reason only – to get the right treatment, preferably curative.

Step 3: Small and large practice reporting options

See the various reporting options for small and large practices for MIPS 2024.

Step 3: Small and large practice reporting options

See the various reporting options for small and large practices for MIPS.

Caveat mTOR revisited: Neurofibromatosis

Targeting the MAPK/ERK and PI3K/AKT/mTOR pathway has led to the use of topical sirolimus for neurofibromas and oral selumetinib for children with plexiform neurofibromas.

The Venetian antithesis: Treating median canaliform nail dystrophy

Median canaliform nail dystrophy is easy to recognize but difficult to treat. Recent reports utilizing tazarotene foam, dupilumab, and marigold offer some promise that warrant further study with appropriate trials.

Skin conditions by the numbers

Find facts and statistics for reporting about dermatology and dermatologic conditions.

Focusing attention on X-linked ichthyosis

This commentary focuses on some new literature about XLI that demands our attention.

Striving to alleviate the physical and emotional scars of central centrifugal cicatricial alopecia

Read the November 4, 2020 DermWorld Insights and Inquiries on central centrifugal cicatricial alopecia.

Tofacitinib: A JAK inhibitor of all trades

Learn more about Tofacitinib: A JAK inhibitor of all trades at aad.org

A potential roadMAP for treating malignant atrophic papulosis

DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, June 1, 2026 Vol. 8, No. 6 Certain skin lesions evoke dread in the dermatologist who encounters them, fearing a poor prognosis for their patient. Examples include a Sister Mary Joseph nodule, a thick melanoma, or rhinocerebral mucormycosis, among

LIDA* rose the insulin requirement

Read the April 14, 2021 DermWorld Insights and Inquiries on localized insulin-derived amyloidosis.

Congenital juvenile xanthogranulomas: Born to be wild (but ultimately mild)

Congenital juvenile xanthogranulomas usually appear early in life, although they may occur in adults.

InCYSTing on searching for explosives

I have enjoyed medical writing and editing since publishing my first article in 1983 when I wrote about a penile Fibroepithelioma of Pinkus (my medical school roommate’s father was the patient).

Breaking through

Go to AAD Home ... Go to AAD Home ... Menu ... Advances in disease pathogenesis and treatments offer new promise for patients with connective tissue disease ... Advances in disease pathogenesis and treatments offer new promise for patients with connective tissue disease ... By Allison Evans, assistant managing editor

Why you should hear about the red ear syndrome

Read the July 22, 2020 DermWorld Insights and Inquiries on red ear syndrome.

2025 MIPS and telehealth highlights

The 2025 MIPS program features some changes, including the introduction of a MIPS value pathway for dermatology. See our highlights on what dermatologists need to know about participating in MIPS.

Weighing in on glucagon-like peptide-1 receptor agonists in dermatology

Glucagon-like peptide-1 (GLP-1) receptor agonists are now approved for weight loss, which may benefit dermatoses associated with excess weight. Dermatologists should be familiar with the potential adverse effects and benefits of these drugs.

Avoid the opioid

Experts offer advice on effective pain management in dermatology. ... Feature ... By Heidi Splete, Contributing Writer, May 1, 2026 Many dermatoses and dermatologic procedures are painful, but consensus on pain management in dermatology is limited, and complicated not only by the individual and varied experience of pain, but also

Will PD-1 inhibitors be msed for Mastocytosis?

The authors evaluated 16 specimens from 12 patients with mastocytosis, using immunohistochemical stains for PD-L1, CD-117, and mast cell tryptase on all specimens.

Spot on! Lentigines in resolved psoriatic plaques

Having treated psoriatic patients throughout my career, there have been innumerable occasions where patients were concerned about pigmentary changes following successful treatment of the plaques. I have usually reassured them that these are postinflammatory pigmentary alterations that should abate with time. Recently, however, there have been a spate of articles

CMS Pays for Communication Technology-based Services, Effective 2019

Given the recent ubiquitous nature of synchronous audio and video applications available for download and the increased use of patient-facing health portals, the Center for Medicare & Medicaid Services (CMS) has determined that a broad range of services can be provided by healthcare professionals via communication technology. ... Remote Evaluation

An encapsulation of palisaded encapsulated neuromas

Case reports and retrospective studies have demonstrated dupilumab’s efficacy in treating bullous pemphigoid. Preliminary data from a prospective trial confirms dupilumab’s therapeutic value. Perhaps approval of dupilumab for bullous pemphigoid is on the horizon.

Oncolytic virotherapy and the dermatologist

My late British cousin Tim, a brilliant, kind, benevolent husband, father, gastroenterologist, and MBA, lost his battle with glioblastoma in 2016 at age 55.* I was hoping that he might be able to get into a trial using an oncolytic virus (OV), but that was not possible.

Rituximab and dermatomyositis: Dr. Samitz would be proud

Read the November 20, 2019 DWII on rituximab and dermatomyositis.

Beware: Discordance abounds among pathologists in the diagnosis of melanocytic neoplasms

Read the December 4, 2019, DWII on discordance among pathologists in the diagnosis of malanocytic neoplasms.

Key messaging in social media about acne

By communicating these key messages on acne, you can help position the specialty while increasing your credibility and raising the profile of your practice. These include the causes of acne, how to care for it, and treatment options.

Sirolumus’s merit for the Kasabach-Merritt phenomenon

We wish to report the following case of an extensive hemangioma of the skin associated with diffuse purpuric manifestations. The course and management of the condition, we believe, are of unusual interest.

Learning about proton pump inhibitor-induced dermatologic adverse reactions is ulcerogenic

How many of your patients are on protein pump inhibitors (PPI) such as Nexium [esomeprazole], Prevacid [lansoprazole], or Prilosec [omeprazole] for GERD? Let me rephrase the question. How many of your patients are NOT on PPI’s?

A tale of two disorders of hypopigmentation: The potential role of Cutibacterium acnes dysbiosis in progressive macular hypomelanosis and lichen striatus

The human (and skin) microbiome is intricately involved in health and disease. Recent studies suggest that dysbiosis may be pathogenic in disorders of hypopigmentation, such as progressive macular hypomelanosis and lichen striatus.

Homing in on hornerin: Breaking down the barrier to understand its crucial role in atopic dermatitis

Maintaining the skin barrier is crucial in managing patients with atopic dermatitis. The pathomechanism(s) of barrier impairment is complex and integrally associated with immune dysregulation. Research on newly discovered proteins in the stratum corneum, such as hornerin, may lead to novel therapeutic interventions.

Key messages when communicating about skin cancer

By communicating these key messages on skin cancer, you can help position the specialty while increasing your credibility and raising the profile of your practice. Skin cancer is the most common cancer in the United States. These are core messages to urge patients to seek screening.

A novel sebum inhibitor for acne vulgaris: A slick maneuver

What a pleasure it is to think about a novel treatment for acne! Honestly, have you gotten excited learning that the “same old, same old” is now available in a cloth or foam?

Tarrying for tapinarof

Read the January 12, 2022 DermWorld Insights and Inquiries on tapinarof.

Top 3 administrative burdens in dermatology and how to tackle them!

Answers in Practice ... By Faiza Wasif and Swapna Pachauri, AADA Practice Management, December 1, 2021 Each month, DermWorld ... tackles issues "in practice" for dermatologists. This month, practice management staff offer tips on managing the top three administrative burdens. A successful dermatology office is established not only on optimal

Increasing evidence for the use of topical timolol for pyogenic granulomas

There are multiple approaches to treating pyogenic granulomas (PGs). If possible, I usually perform a shave biopsy and electrodesiccate the base of the lesion.

Preventing and treating Trichophyton indotineae

Because confirmatory testing may take weeks, it is reasonable to empirically start treatment for T. indotineae based on patient epidemiologic and clinical features while awaiting confirmatory testing. Potassium hydroxide (KOH) preparation of skin scrapings should be performed in clinic, whenever possible, to confirm fungal infections.

Tackling itch

Understanding and treating chronic itch ... Feature ... By Allison Evans, Assistant Managing Editor, April 1, 2022 Itch, or pruritus, is a common symptom (and condition) that is considered one of the 50 most prevalent conditions worldwide — an estimated 15% of the population suffers from chronic pruritus. Speak to

Medical vs. cosmetic dermatology: Who is doing what?

Facts at your Fingertips ... By Emily Margosian, assistant editor, January 1, 2019 Despite ongoing discussion about the role of cosmetics in the specialty, data from the 2017 AAD Practice Profile Survey indicate that medical dermatology remains the primary focus of dermatology practitioners across all types. However, dermatologists spend the

Teledermatology workflow for small practices

Use the workflow below to help you implement or improve your teledermatology operations. This version is designed for solo or small practices.

The congenital perineal groove: Defective recognition of a dermal defect

It has been nearly half a century since Stephens first detailed the perineal groove (PG) as a congenital malformation consisting of three features.

Pineapple and cicatricial pemphigoid: A need to dole out more studies

The benefits of pineapples have been touted in folk medicine for years. Increasing knowledge of its active ingredient bromelain has lead to a therapeutic pineapple renaissance.

Write this down if your patient has multiple PENS: Look further

Papular Epidermal Nevus with Skyline Basal Cell Layer (PENS) was first described by Torrelo et al. They detailed 5 infants with solitary or multiple 1 to 7 mm congenital keratotic papules.

Coming to grips with lymphocytic thrombophilic arteritis

Read the May 18, 2022 DermWorld Insights and Inquiries on lymphocytic thrombophilic arteritis.

Lipodystrophia semicircularis: A lipoatrophy not to get depressed about

Read the Nov. 2, 2022 DermWorld Insights and Inquiries on lipodystrophia semicircularis.

Rounds on pityriasis rotunda

Pityriasis rotunda is a striking dermatosis with many reported associations, most notably as a paraneoplastic process in some cases.

What's hot?

What's hot ... May 29, 2018 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Edward W. Cowen, MD, MHSc ... You may be surprised to learn that a ... new organ’ in the skin was recently identified.

Of strife and SDRIFE

A conceivable Yelp review: I was so uncomfortable with a nasty rash on my butt, armpits and groin – I called a dermatologist who was recommended to me by my mother-in-law. I was so upset with that doctor – I waited for an hour and a half! When he finally

Sirolimus for microcystic lymphatic malformations: Caviar for frog spawn

Recently, our understanding of lymphatic malformations (LMs) has vastly expanded. Genetic advances have focused on the PI3K/AKT/mTOR pathway allowing the use of mTOR inhibitors for those lesions involved in this pathway.

Paraneoplastic syndromes (PNS) associated with merkel cell carcinoma are analogous to small cell cung Cancer: A comparison to other lung cancers

Merkel cell carcinomas (MCC) are neuroendocrine tumors associated with the Merkel cell carcinoma polyomavirus in greater than 80% of tumors (1). Small cell lung cancer, another neuroendocrine tumor, is associated with paraneoplastic syndromes (PNS) in up to 20% of cases, notably the syndrome of inappropriate antidiuretic hormone (SIADH) and Lambert-Eaton

Transplantation dermatology: Race matters

December 3rd, 2017 will mark the 50th anniversary of the first human-to-human heart transplant performed by the late South African cardiothoracic surgeon, Christaan Barnard.

The role of GLP-1s in dermatology

Dermatologists discuss how the use of GLP-1s has offered potential new avenues for patients with chronic inflammatory skin diseases. ... Feature ... By Allison Evans, Assistant Managing Editor, January 1, 2026 Over the past five years, the approvals of glucagon-like peptide-1 receptor agonists (GLP-1s), particularly semaglutide and tirzepatide, have sparked

Nonepidemic Kaposi sarcoma: The fifth dimension

By Warren R. Heymann, MD Oct. 16, 2019 Vol. 1, No. 32  ... For more than a century, since first described in 1872 by Moritz Kaposi* as "idiopathic multiple pigmented sarcoma," dermatologists focused on classical Kaposi sarcoma (KS) — violaceous patches, plaques, and tumors on the lower extremities of

Atrophic tinea versicolor: Knowledge about its pathogenesis is hypertrophying

In the entry “Atrophic Tinea Versicolor: More Than a Mirage” (April 22, 2016), I learned that the atrophic appearance of some cases of tinea versicolor is not just an optical illusion.

Reopening the dermatologic surgery office in the COVID-19 era

Read the May 20, 2020 DermWorld Insights & Inquiries article on reopening dermatology offices in the COVID-19 era.

The ironclad promise of ferroptosis

Read the Jan. 25, 2023 DermWorld Insights and Inquiries on the ironclad promise of ferroptosis.

Office preparedness

Learn how to get testing for patients with suspected cases of measles, how to prepare your clinic for cases, what PPE staff and patients need, and what to do in case of staff exposure.

Hand-wringing over the histology of mechanic’s hands and other cutaneous manifestations of dermatomyositis

Of all the cutaneous manifestations of dermatomyositis (DM) – the heliotrope rash, Gottron’s papules, Gottron’s sign, shawl sign, holster sign, flagellate erythema, photosensitivity, poikiloderma, periungual erythema, periungual telangiectasis, Samitz sign, pruritic erythema of the scalp, and panniculitis – none has perplexed me more than mechanic’s hands (MH).

February 23, 2022

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 23, 2022 ... Frontal fibrosing alopecia: The effects of sunscreens and moisturizers DermWorld Insights and Inquiries : The vexing verruciform xanthoma DermWorld Young Physician Focus : The patient experience —

A checkup on immune checkpoint inhibitor-induced subacute cutaneous lupus

Read the March 15, 2023 DermWorld Insights and Inquiries on immune checkpoint inhibitor-induced subacute cutaneous lupus.

Interfering with interferon Gamma: The mechanisms behind acquired resistance to PD-1 inhibitors for melanoma

Astounding major advances in targeted therapies for melanoma, most notably by PD-1 blockade, have given hope and life to patients with metastatic melanoma. Approximately 30 % of advanced melanoma patients experience tumor responses from checkpoint blockade monotherapy, with better clinical responses seen with the combination of anti-PD-1 and anti-CTLA-4 antibodies.

Life insurance 102: Five success factors when using permanent life insurance

Money Matters ... David B. Snyder, JD, CLU ... ® ... , is an attorney, author, and financial advisor at the wealth management firm OJM Group. He covers financial issues for dermatologists in this quarterly ... Dermatology World column. ... By David B. Snyder, JD, CLU, September 2, 2019 In

This month's news from across the specialty

What's hot ... November 1, 2019 In this monthly column, members of  ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty.   ... EDWARD W. COWEN, MD, MHSc Adalimumab was approved in 2015 for the treatment of moderate and severe hidradenitis suppurativa (HS). It is

I don’t know JAK — but I will! Ruxolitinib improving chilblain lupus erythematosus

The JAK inhibitors are among the current darlings of treating autoimmune diseases. Recent articles about tofacitinib for vitiligo (1) and alopecia areata (2) have been reported in the lay press with considerable fanfare.

Dermatomyositis oddities: Could one be responsible for the other?

So much about dermatomyositis (DM) has intrigued me since medical school. Over the years, I have probably read more about this disease than any other malady. I am always amazed how I much more there is to learn.

Platelet rich plasma: Good for whatever ails you?

Okay, okay, I admit it. The first time I ever heard of injecting autologous platelet rich plasma (PRP) for pattern alopecia, my suspicion was that it was being sold by the proverbial snake-oil salesman. I did my utmost to ignore it, but increasingly its use is being reported, and patients

This month's news from across the specialty

What's hot ... December 1, 2020 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Harry Dao Jr., MD Choice and transparency dominate our landscape. It is hard to believe that it was only 2013 when the FDA

Sparking the interest in Spark nevus

For the clinician, a Spark nevus may have been encountered under different designations such as Clark/dysplastic nevus and Spitz nevus assigned with varying degree of atypia. The designation Spark nevus accounts for a combination of histopathologic findings present in Spitz and Clark nevus long observed by pathologists. Though the nevus

Getting a toehold on subungual tumors: Aneurysmal bone cysts join the club

Subungual tumors make me nervous. I realize that most are benign (subungual exostosis, osteochondroma, onycholemmal cyst, glomus tumor, pyogenic granuloma, wart, fibroma, acral fibromyxoma), however subungual malignant lesions (squamous cell carcinoma, keratoacanthoma, melanoma) occur. A delayed diagnosis can result in a profoundly adverse outcome.

Seeing red with dupilumab

Read the March 1, 2023 DermWorld Insights and Inquiries on seeing red with dupilumab.

Side gig

Go to AAD Home ... Go to AAD Home ... Menu ... What can physicians do in addition to clinical services, and how do you get started? ... What can physicians do in addition to clinical services, and how do you get started? ... By Emily Margosian, assistant editor While

Wolf’s isotopic response: Where and when

Although the nature of Wolf’s isotopic response may be debated among dermatologists, clinicians must recognize that new rashes and tumors may appear in sites of previously healed sites from other disorders, most frequently herpes zoster.

The journey of focal dermal hypoplasia: From description to inspired therapy

The dermatologic community lost a giant in 2014 with the passing of Robert W. Goltz, MD at the age of 90. Dr. Goltz was not only responsible for describing focal dermal hypoplasia (FDH), but also multicentric reticulohistiocytosis, generalized elastolysis, and the nevoid basal cell carcinoma syndrome (with his good friend

Striae due to bartonella is a stretch

I met a woman in her early 20’s who is being treated for chronic Lyme disease and Bartonella infections with multiple courses of antibiotics. During my examination, I noted several old white atrophic striae on her hip and leg. Her mother, who was accompanying her, stated matter-of-factly, “Those are due

Hantavirus for the Dermatologist

Hantaviruses are enveloped RNA viruses of the Bunyaviridae family. They are found worldwide and are carried by specific rodent species (mice, rats, and voles,) in each endemic geographic region.

The medical word to watch in 2018: Dysbiosis

With increasing rapidity, new words enter the dermatological lexicon, reflecting concepts that change our perceptions of disease and treatment. Recent examples include “comorbidities”, “programmed cell death inhibition” and “teledermatology”. The word to watch in 2018 is “dysbiosis”.

Angiosarcomas and morbid obesity: An enormous problem

More than a third of US adults are obese (body mass index, BMI greater than 30), per the CDC website. Patients with severe obesity (BMI greater than 40) or morbid obesity (BMI greater than 50) have far more serious health consequences than those who are moderately obese.

Dermatomyositis takes your breath away!

The dermatopulmonary syndrome (DPS) is a newly recognized subset of dermatomyositis (DM) associated with anti-MDA5 (melanoma differentiation-associated gene 5) antibodies. The hallmarks are palmar papules, cutaneous ulceration, a high risk of severe interstitial lung disease (ILD), a low risk of myositis, and a low risk of malignancy.

February 8, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 8, 2023 ... A review of newer agents for alopecia areata DermWorld Insights and Inquiries : A surgeon’s primary intention is to reduce secondary infection CDC investigating possibility of treatment-resistant

Studying skin aging never gets old: The potential role of oxytocin

Read the October 14, 2020 DermWorld Insights and Inquiries on oxytocin and aging skin.

Netherton syndrome: From apex to nether

Read the March 31, 2021 DermWorld Insights and Inquiries on Netherton syndrome.

Acquaint Yourself with the MPFSDB Indicators

The MPFSDB provides more than just a list of carrier-specific maximum fees per procedural code. The MPFSDB is the national database used by MACs to ensure that claims processing is consistent nationally. Medicare uses this fee schedule when paying for the following services: ... Professional services of physicians and other

Something from nothing: The role of random skin biopsies

As dermatologists we hone our skills on visual diagnostic clues, allowing us to choose optimal lesions to biopsy for clinical-pathologic correlation. The concept of random skin biopsies (RSB) of normal skin searching for pathology may seem foreign (or heretical); however, in the right circumstances, it may yield vital diagnostic information.

Nailing the diagnosis of the BAP1 tumor predisposition syndrome

Patients with polydactylous onychopapillomas mandate evaluation for the BAP1-tumor predisposition syndrome.

A seasoned approach to treating the “salt and pepper” dyspigmentation of systemic sclerosis

Read the Feb. 8, 2023 DermWorld Insights and Inquiries on surgeons' primary intention to reduce secondary infection.

October 27, 2021

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 27, 2021 ... COVID-19 and nails: A review of clinical findings DermWorld Insights and Inquiries : Taking woolly hair to heart Derm Coding Consult : CMS revises Advance Beneficiary Notice

Naltrexone therapy for Hailey-Hailey disease: Confirming my addiction to evidence-based medicine

I was fascinated by a presentation at the recent World Congress of Pediatric Dermatology discussing improvement of epidermolysis bullosa wounds with topical CBD (cannabis) oil. I asked the presenter how he came up with his hypothesis. He acknowledged that the idea was not his – it came from EB families

Dupilumab treatment of bullous pemphigoid: Hoping for approval on the double

Case reports and retrospective studies have demonstrated dupilumab’s efficacy in treating bullous pemphigoid. Preliminary data from a prospective trial confirms dupilumab’s therapeutic value. Perhaps approval of dupilumab for bullous pemphigoid is on the horizon.

March 1, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 1, 2023 ... Isotretinoin: Risk of IBS, ulcerative colitis, and Crohn’s disease? DermWorld Insights and Inquiries : Seeing red with dupilumab IL-17 inhibitors in psoriasis patients in the real world

The H syndrome – Understanding Y

Read the April 15, 2020 DermWorld Insight and Inquiries on H syndrome.

Coming clean on chlorhexidine-induced dermatoses

Chlorhexidine may induce allergic contact dermatitis or other dermatoses. This should be kept in mind to avoid delay in diagnosis.

Fooled again: Misdiagnosing cutaneous follicle center lymphoma

Learn more about Fooled again: Misdiagnosing cutaneous follicle center lymphoma at aad.org

Atopic dermatitis: Up in smoke!

The etiology of atopic dermatitis (AD) is multifactorial, with genetic mutations of the filaggrin mutations affecting barrier function, immunodysregulation of the TH2 pathway, and environmental triggers being of primary importance. AD has long been associated with autoimmune diseases such as vitiligo and alopecia areata.

Idiopathic facial aseptic granuloma — Have we met?

I’m racking my brain wondering if I have ever seen a case of idiopathic facial aseptic granuloma (IFAG)– I know that I never made the diagnosis because I had never heard the term until I read the first reference. I surmise that I have seen and misdiagnosed it as an

MIPS Highlights for 2021

Access the Academy's highlights of the Final Rule for MIPS for the 2021 reporting year. These updates are tailored to include the information most important to dermatologists. Program updates for 2021 are relatively modest compared to some previous years, but higher participation thresholds and other changes merit careful review.

Managing hair loss

What has research revealed about the pathogenesis of androgenetic alopecia, alopecia areata, and central centrifugal cicatricial alopecia as well as new potential therapeutics? ... Feature ... By Allison Evans, assistant managing editor, September 1, 2021 To those outside the world of dermatology, hair is sometimes perceived to be a cosmetic

Asking psoriasis patients to open their mouths and say “Ahhh”

A thorough cutaneous examination includes the hair, nails, and mucous membranes (lips, intraoral mucosa, conjunctiva, genital).

Key messages for social media about hair loss

By communicating these key messages on hair loss, you can help position the specialty while increasing your credibility and raising the profile of your practice. Review key messages on causes of hair loss, the psychosocial impacts, and treatment options.

A presidential viewpoint: “Nobody knew that benign vascular lesions of the lip could be so complicated”

Well, maybe not as befuddling as replacing Obamacare, but there may be occasional difficulties in diagnosing benign vascular lesions of the lip, with implications for appropriate therapy.

The rosy reality of coffee

I have never discouraged caffeine in rosacea patients, because of a brilliant study by Jonathan Wilkin that I read early in my residency.

Keeping up is hard to do: The need for true grit

One of the daunting challenges in practicing dermatology (or any branch of medicine) is keeping abreast of advances in the literature to optimize patient care. As a clinician-educator, I have always had an interest in how we learn best. For full disclosure, I am a dermatologist, not a psychologist, nor

Melanoma fact sheet | AAD

Find facts and statistics for reporting about melanoma skin cancer.

Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy — Measure 176

This measure encourages tuberculosis (TB) prevention for patients receiving a first course of therapy using a biologic DMARD. Physicians should ensure TB prevention prior to treatment either through documenting a previous TB test or performing a TB test (PPD, IFN-gamma release assays, or other appropriate method) in the medical record

Win back time with AAD’s top-rated prior authorization tool

Answers in Practice ... By Olivia Barry, Manager, Practice Management, October 1, 2025 Each month, DermWorld ... tackles issues "in practice" for dermatologists. This month, practice management staff discuss what dermatology practices need to know about the Academy’s prior authorization tool. For busy dermatology practices, navigating prior authorizations can feel

Paradoxical biological reactions and Grandma Dora’s waterbed

Read the January 22, 2020 DWII on paradoxical biological reactions.

Coding and documentation — Your best defense

Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Senior Manager, Coding and Reimbursement, October 1, 2025 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . Accurate and thorough documentation in the medical

New American Academy of Dermatology survey: increasing number of Americans at risk of skin cancer despite knowing how to protect themselves

Board-certified dermatologist urges public to practice safe sun ROSEMONT, Ill. (April 30, 2024) — Abby Weiner knew the dangers of unprotected sun exposure long before she was diagnosed with skin cancer. As someone with fair skin and freckles, the 43-year-old mother of three says she has always been diligent about

A metabolic pathway that may allow dermatologists to run rings around porokeratoses

Learn more about A metabolic pathway that may allow dermatologists to run rings around porokeratoses at aad.org

2023 MIPS and telehealth highlights

The 2023 MIPS program remains mostly the same from 2022, but there are also important changes, such as the end of performance bonuses, the start of MVPs, and more.

AESOP: The ants and the grasshopper

Dermatologists should consider the diagnosis of AESOP (Adenopathy and Extensive Skin patch Overlying a Plasmactyoma) presented as predominantly truncal erythematous patches or sclerodermoid plaques. A significant number of cases are associated with polyneuropathy and/or POEMS syndrome.

Ubiquitous ubiquitination

While perusing the Journal of Investigative Dermatology, I was intrigued by the theory that a variant of epidermolysis bullosa simplex (EBS) may be due to “dysregulation of autoubiquitination” caused by mutations in KLHL24 (Kelch-like family member 24).

Blasé about the acronym BLAISE (Blaschko Linear Acquired Inflammatory Skin Eruptions)

I always enjoy rendering the diagnosis of lichen striatus – parents are concerned, the rash is benign, and usually resolves within months. The only downer is trying to answer the inevitable question of “Why did my child get this?” and I morph from the sagacious physician to a dunce,

Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy — Measure 176

This measure encourages tuberculosis (TB) prevention for patients receiving a first course of therapy using a biologic DMARD. Physicians should ensure TB prevention prior to treatment either through documenting a previous TB test or performing a TB test (PPD, IFN-gamma release assays, or other appropriate method) in the medical record

Checking in on immune checkpoint inhibitors

Immune checkpoint inhibitors offer hope for non-melanoma skin cancer patients ... Feature ... By Heidi Splete, Contributing Writer, July 1, 2022 Patients with advanced non-melanoma skin cancer see new hope on the horizon, thanks to recent developments in the number and effectiveness of new drugs to improve survival. ... "Patients

The aryl hydrocarbon receptor: Tapinarof is taking off

The aryl hydrocarbon receptor plays a key role in inflammation. Understanding its pathophysiology has led to new therapeutic agents such as tapinarof, which is approved for psoriasis and atopic dermatitis, and used off-label in lupus, vitiligo, ichthyotic diseases, and perioral dermatitis.

Vitiligo, autoimmunity, and cancer?

While attending the pre-AAD pediatric dermatology seminar in Orlando, I received a call from my college roommate in mid-afternoon. My close friends know not to call during working hours, unless it’s urgent – naturally, I get nervous when the caller ID reveals their identity. I stepped away from the lecture

Not just for boys: X-linked erythropoietic protoporphyria

I was anxiously awaiting the results of erythrocyte protoporphyrin levels obtained from a 4 year-old boy who avoids sunlight because his “skin hurts” when not in the shade. Until I read the article by Balwani, et al (1), I was unaware of the existence of X-linked erythropoietic protoporhyria (XLEPP), also

Making a pitch for the C-reactive protein/albumin ratio

The C-reactive protein/albumin ratio (CAR) is a new measure for assessing disease severity and prognosis in inflammatory and neoplastic disorders. Dermatologists will increasingly encounter the CAR in daily practice.

We’re in hot water! Vibrio vulnificus infections are heading north

Read the December 16, 2020 DermWorld Insights and Inquiries on Vibrio vulnificus infections.

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Nov. 15, 2023 ... Platelet-rich plasma vs. minoxidil in androgenetic alopecia treatment DermWorld Insights and Inquiries : The woolly culprit — Lanolin revealed as an uncommon cause of dermatitis on normal

December 18, 2019

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / December 18, 2019 ... Which physicians were sued most in 2019? DW Insights and Inquiries: Holiday greeting 2020 — eyeing dermatology’s future New DW Academy Insider coming in 2020 Does teledermatology

April 10

Learn more about April 10 at aad.org

Cover your assets

Go to AAD Home ... Go to AAD Home ... Menu ... Experts offer tips on getting the most out of malpractice insurance ... Experts offer tips on getting the most out of malpractice insurance ... By Ruth Carol, contributing writer You may not be paying for your medical malpractice

The odd couples

Unlikely partners fuel new consolidation trends ... Feature ... By Ruth Carol, contributing writer, June 1, 2021 While the number of physicians becoming hospital employees and the number of hospitals merging into health systems continue to grow, some unlikely players are changing the consolidation landscape. Pharmacy benefits managers are merging

An appealing step closer to targeted topical therapies

Read the April 5, 2023 DermWorld Insights and Inquiries on an appealing step closer to targeted topical therapies.

Early-onset hypertension associated with extensive capillary malformations: A new worry to raise dermatologists’ blood pressure

Patients presenting with extensive capillary malformations (port wine stains) on the trunk and extremities should be routinely screened for early-onset hypertension.

Coding and documentation for hyperhidrosis

Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Manager, Lead Coding and Reimbursement Strategist, November 1, 2024 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . Clear and concise documentation is essential

Stress^2 + Hormones^2 = Acne^2

Learn more about Stress + Hormones = Acne at aad.org

Intermediate and complex repair

Access valuable Academy update on codes that have been revised for 2020, particularly those associated with intermediate and complex repairs.

Intralesional triamcinolone for hidradenitis suppurativa and thoughts on confirmation bias

Anyone who has treated the scourge of hidradenitis suppurativa (HS) has probably injected inflamed nodules and cysts with triamcinolone (TAC) successfully, resulting in very grateful patients.

Systemic amyloidosis presenting as nail dystrophy (and inducing onychophagia in the reviewer)

I admit it – I am plagued with onychophagia (nail biting). It is a life-long habit, and now that I’m 61, I presume that this foible will remain with me to the end. It is worse with anxiety – after reviewing the following articles, I’m down to the hyponychium!

A dermatologic riddle: How is IgG4-related ophthalmic disease parliamentary?

IgG4-related disease (IgG4-RD) is a chronic fibro-inflammatory disorder that potentially affects virtually every organ system. It characteristically affects middle-aged men, although for lesions of the head and neck, there is an equal gender distribution.

Prolactin and its role in stress-induced psoriasis: Milking the data

Patients will readily acknowledge that stress worsens their psoriasis. When asked how this happens, I respond by mentioning the “mind-body connection” using the term “psychoneuroimmunology”; patients nod in agreement, feigning understanding; appropriately so, because frankly, I don’t understand it either.

Old stains leaving new marks in dermatology

Dermatologists are often confronted by patients who simply cannot afford prescription medications. Repurposed, inexpensive drugs for new indications are satisfying both medically and economically. The “rediscovery” of gentian violet is such an agent.

Linear and whorled nevoid hypermelanosis: Past reflections and future directions

Dr. Kalter was the first to accurately detail Linear and Whorled Nevoid Hypermelanosis (LWNH) nearly 30 years ago. In 1994, I was shocked and saddened to learn of her death from cancer at age 40. When brilliance leaves us prematurely (think Mozart, Gershwin, Van Gogh, et cetera) one can only

My fair-weather therapeutic friends for alopecia areata

We were never best of friends, but we got along well most of the time. The relationship seemed to work, with rare moments of ecstasy, but was irritating all too often. There were no major conflagrations; we just drifted apart.

The globalization of monkeypox

Read the May 25, 2022 DermWorld Insights and Inquiries on the globalization of monkeypox.

Probing pediatric pigmented purpuras

Read the October 20, 2021 DermWorld Insights and Inquiries on pediatric pigmented purpuras.

What dermatology practices need to know about laws protecting pregnant and lactating employees

Legally Speaking ... Robert M. Portman, JD, MPP, is a health care attorney with Powers Pyles Sutter & Verville, in Washington, D.C. ... By Ben Tesdahl, JD, LLM, Jason Qu, JD, and Rob Portman, JD, MPP, September 1, 2024 Every month , DermWorld ... covers legal issues in "Legally Speaking."

Saving face: The importance of recognizing facial discoid dermatosis

Read the Feb. 22, 2023 DermWorld Insights and Inquiries on recognizing facial discoid dermatosis.

More than just poison ivy...

Go to AAD Home ... Go to AAD Home ... Menu ... Identification and treatment of hazardous plant exposures ... Identification and treatment of hazardous plant exposures ... By Emily Margosian, content specialist For most, knowledge of hazardous plants is limited to the phrase, “leaves of three, leave them be.”

Long COVID has a lot of nerve

COVID-19 is associated with multiple neurological complications. Dermatologists may encounter patients experiencing paresthesias due to a small fiber neuropathy affecting A-delta and C dermal neuronal fibers.

Understanding and managing vulvovaginal itching

Clinical Applications ... By Kathryn Schwarzenberger, MD, FAAD, October 1, 2025 In this month's Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Gil Yosipovitch, MD, FAAD, and Kayla D. Mashoudy, MD, about their American Journal of Clinical Dermatology ... paper, ' Scratching the Surface: A Comprehensive Guide

Pregnant with possibility: Rituximab prophylaxis for pemphigoid gestationis

I was taken aback by the report of anhydramnios in two women with pemphigoid gestationis (PG) resulting in the death of the newborn babies within days of birth. Each child died of sepsis. (1)

This month’s news from across the specialty

What’s hot ... September 1, 2023 In this monthly column, members of the  ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty.   ... Craig Burkhart, MD, MS, MPH, FAAD The HPV vaccine is a safe and effective method of preventing cancer, but parental hesitancy toward vaccine

Eruptive nevi: Trying to connect the dots

Eruptive nevi are striking – they may appear after a variety of disorders, including Stevens-Johnson/toxic epidermal necrolysis, primary blistering diseases, trauma, immunosuppression (from disease or iatrogenically-induced), PUVA therapy, or idiopathically. There are also several reports in the literature for eruptive Spitz nevi and blue nevi.

Excision and biopsy of soft tissue tumors: Coding, payment, and site-of-service considerations

Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Senior Manager, Coding and Reimbursement, February 1, 2026 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . Accurate coding and understanding of payment implications

October 31

Learn more about October 31 at aad.org

2020 DW Insights and Inquiries archive

Explore past issues of DW Insights and Inquiries that were published in 2020.

Do polygenic risk scores have potential utility in determining risk for dermatologic disease?

Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, February 1, 2020 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Maryam Asgari, MD, MPH, about

Varicella-zoster

Varicella-zoster virus (VZV) is a DNA herpesvirus in which primary infection produces varicella (chickenpox).

CXCR4 antagonist therapy based on a WHIM syndrome

Advances in understanding the pathomechanisms of WHIM syndrome are the prelude to treating this syndrome — and other diseases — with CXCR4 antagonists.

Demodectic eruptions: More than you mite have imagined

Read the April 26, 2023 DermWorld Insights and Inquiries on Demodectic eruptions. Although the precise role of Demodex mites remains to be defined in disorders such as rosacea, these mites could play a role in other diseases, the most under-recognized possibly being so-called pigmented demodicidosis.

Becoming “sensitized” to the clinical utility of the term “urticarial dermatitis” (a subtype of the dermal hypersensitivity reaction pattern)

Consider using the term “urticarial dermatitis” in your dermatologic practice. This can help guide your diagnostic evaluation, enhance therapeutic relationships, and set expectations for prognosis.

The mysteries of malakoplakia

Any dermatology resident preparing for their board exam will tell you that malakoplakia is defined by Michaelis-Gutmann bodies and von Hansemann cells. Somehow reciting those terms can give a person a false sense of understanding. My perspectives about malakoplakia are based solely on my reading – I have never seen

MIPS 2022 program highlights

Learn about important updates to the Merit-based Incentive Payment System (MIPS) for 2022. Learn about new eligibility requirements, thresholds, category weights, and more.

Melanoma in situ: The power of one (centimeter)?

I remember Marie. She was a delightful elderly woman whom I would see for routine follow-up following an excision of her melanoma in situ (MIS) from her right arm. I will never forget my astonishment upon feeling the large lymph node in her right axilla, the first metastasis of her

Lending a helping hand to our patients with Dupuytren’s disease

Read the Oct. 26, 2022 DermWorld Insights and Inquiries on Dupuytren’s disease.

Contract clarity 101

Answers in Practice ... By Olivia Barry, Manager, Practice Management, August 1, 2026 Each month, DermWorld ... tackles issues "in practice" for dermatologists. This month, practice management staff offer a guided tour of your first employment contract. Navigating physician contracts can feel overwhelming, especially when reviewing your first offer. After

Advocacy Update Mar. 4, 2025

The Academy urged CMS and CDC to recognize dermatologists as Clinical Laboratory Improvement Amendments (CLIA) laboratory directors.

The intimate dance of Staphylococcus aureus and cutaneous T-cell lymphoma

Patients with cutaneous T-cell lymphoma are at risk for Staphylococcal skin infection and sepsis. Staphylococcus aureus colonization and infection may also fuel CTCL progression. Judicious use of antibiotics and preventive measures are essential in treating these patients. Current research may yield novel non-antibiotic management strategies.

April 5, 2023

Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 5, 2023 ... What’s the effect of probiotics on skin photoaging? DermWorld Insights and Inquiries : An appealing step closer to targeted topical therapies Does nicotinamide prevent keratinocyte cancers in